PhARMACY - Minnesota Pharmacists Association

Transcription

McKesson Delivers
the Industry’s Best Service
So You Can Focus on What Really Matters: Your Patients
Success begins with knowing your
business. Your McKesson representative
will conduct an annual profitability
analysis to track your strengths, find
new opportunities, and understand
your unique business issues.
Being your strategic advisor is just the
start. With McKesson, you'll get the
industry's best service and innovative
programs that can help you enhance
profitability—from managed care and
generics, to automation and best-inclass front-end services.
Most important, you'll get a partner
committed to promoting your interests
so you can focus on providing the
personalized care that sets you apart.
2
Minnesota Pharmacist Winter 2012
n
Call
McKesson
Calltoday
today to
to learn
learn how
how McKesson
can
canhelp
help build
build your
your independent
independent
pharmacy’s
pharmacy’ssuccess.
success.
Kim Diemand,
Diemand Vice President Sales
Kim
Vice President-RxOwnership
Todd
Bender, District Sales Manager
NorthCanada
Central Distribution
Region
Little
Center
651.484.4811
Todd Bender
District Sales Manager
Little Canada Distribution Center
651.484.4811
MPhA Board of Directors
Executive/Finance Committee:
President: Scott Setzepfandt
Past-President: Brent Thompson
President-Elect: Martin Erickson
Secretary-Treasurer: Bill Diers
Speaker: Meghan Kelly
Executive Vice President: Julie K. Johnson
Rural Board Members:
Eric Slindee
Mark Trumm
Metro Board Members:
Cheng Lo
James Marttila
At-Large Board Members:
Tiffany Elton
Tim Cernohous
Amy Sapola
Jill Strykowski
Jason Varin
Student Representation:
Duluth MPSA Liaison: Jeremy LeBlanc
Minneapolis MPSA Liaison: Kandace Schuft
Ex-Officio:
Rod Carter, COP
Julie K. Johnson, MPhA
MSHP Representative
Pharmacy Technician Representative:
Barb Stodola
MINNESOTA PHARMACIST
Official publication of the Minnesota Pharmacists Association.
MPhA is an affiliate of the American Pharmacists Association,
the American Society of Consultant Pharmacists, the Academy
of Managed Care Pharmacy, and the National Community
Pharmacists Association.
Editor:
Julie K. Johnson
Managing Editor, Design and Production:
Anna Wrisky
The Minnesota Pharmacist (ISSN # 0026-5616) journal
is published quarterly by the Minnesota Pharmacists
Association, 1000 Westgate Drive, Suite 252, St. Paul,
MN 55114-1469. Phone: 651-697-1771 or 1-800-4518349, 651-290-2266 fax, [email protected]. Periodicals
postage paid at St. Paul, MN (USPS-352040).
Postmaster: Send address changes to Minnesota
Pharmacists Association, 1000 Westgate Drive, Suite 252,
St. Paul, MN 55114-1469.
Article Submission/advertising: For writer’s
guidelines, article submission, or advertising opportunities, contact the editor at the above address or email julie@
mpha.org.
Bylined articles express the opinion of the contributors and do not necessarily reflect the position of the
Minnesota Pharmacists Association. Articles printed in this
publication may not be reproduced in any manner, either
in whole or in part, without specific written permission of
the publisher.
Winter 2012
Volume 66. Number 1, ISSN 0026-5616
in this issue
President’s Desk
A Valuable Insight: Patients Appreciate Extra Effort. . . . . . . . . . . . . . . . . . . . . . . . . 4
Executive’s Report
Remembering the Dream Weaver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
pharmacy and the law Recordkeeping Isn’t that Important, is it? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
features
Walgreens: “America’s Premier Pharmacy” Lives Up to its Self-Image . . . . . . . . . . . 8
Drug Dosing Based on Kidney Function: A Survey of Minnesota Pharmacists. . . . 10
Minnesota Practice-Based Research Network: An Update. . . . . . . . . . . . . . . . . . . . 14
Home Care: A New Frontier for Pharmacy Practice . . . . . . . . . . . . . . . . . . . . . . . . 18
MPhA Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Committees and Task Forces. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
MPhA Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Community Pharmacy Defense Fund. . . . . . . . . . . . . . . . . . . . . 24
Pharmacy Future Fund. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25
MPhA Award Nomination Form . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Legislative Directory. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Pharmacy Resources. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2012 MphA Award Categories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Advertisers
Dakota Drug Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
McKesson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2, 39
Minnesota Pharmacists Foundation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
MPhA Career Center. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
PACE Alliance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17, 39
Pharmcists Mutual Companies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Pharm PAC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Pharmacy Quality Commitment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Acceptance of advertisement does not indicate endorsement.
n
3
president’s desk
A Valuable Insight:
Patients Appreciate Extra Effort
by Scott Setzepfandt, RPh, MPhA President
“Thank you, Tia!”
Get out from behind
the counter and ask!
One of the more rewarding aspects of being a community pharmacist is when your patient thanks you for providing good counseling, especially when you aren’t expecting it.
Pharmacists are well trained to provide good drug therapy management. They do it every day, and for the most part don’t even
think about the valuable service they are providing. It’s a humble
bunch of professionals who really don’t expect accolades for doing
their job well. On the other hand, there are barriers in place that
make it difficult to do just that.
A study was reported in the Journal of the American Pharmacist
Association last summer that looked at pharmacy services from
the patient perspective.1 In that study, more than 90% of those
surveyed indicated a desire for pharmacist-provided information
or that written material was insufficient when obtaining a new
prescription. Even on refills, nearly half surveyed indicated they
wanted more information than simply how many refills were left.
The study also looked at barriers to getting the information they
desired. One might think the obvious barrier is a lack of privacy
due to the layout of the pharmacy. Surprisingly, from the patients’
perspective, this came up only 4% of the time. It is reassuring,
too, that only 1.5% indicated they did not trust the pharmacist
to provide good information. On the other hand, the perception
that pharmacists were not “approachable” came up 18.7% of the
time. But 63% of the patients reported the largest barrier was the
patient him/herself. Reasons cited: lacking time 9.7%, perceiving no need for info 9.7%, lacking initiative 20.0% and fear or
embarrassment at 24.2%.
The article contains much more data, but suffice to say patients
want to interact and receive information from pharmacists — but
aren’t motivated or sure how to do so or are restrained by fear
or embarrassment to reach out. This is valuable insight. We may
want to provide counseling, but how do we reduce the barriers?
How do we overcome both the barrier of being perceived as unapproachable as well as self-imposed barriers by the patient?
One way is to simply get out from behind the counter and ask.
The other day I was getting some groceries and decided to swing
by the pharmacy area to see what niacin they had on the shelf.
My doctor recently informed me that my HDL/LDL ratio needed
4
n
improvement; along with increased exercise he recommended
I start taking niacin. So there I was, checking out the nutrition
shelves looking for it.
Out from behind the counter came Tia Paulson, PharmD. She
asked me if I needed any help. Always curious about how well
pharmacists counsel, I put my patient hat on and played ignorant
(some would argue that isn’t a hard task for me…but that’s a
whole different article). I told Tia my doctor advised that I start
taking niacin daily and asked what the difference was and what
she would recommend. She explained the differences of the ones
they had in stock, told me about what type of side effect I might
experience and recommended when I should take it. It was a short
exchange but she answered all of my questions clearly and in a
reassuring manner.
I put the bottle in my cart and went about finishing the rest of my
shopping. As I rolled my cart around the store I reflected on how
nice an exchange that was, how interested Tia seemed in my wellbeing, and how useful her information would be for the patient
who has no real health care background. I also thought about how
rarely the pharmacist is made aware that what they did was very
much appreciated. Sure, I gave Tia a typical “thanks,” but it just
didn’t seem like enough.
So before I left the store I went back to thank Tia. I told her
who I was, thanked her again for doing a great job of counseling
and asked if it was OK if I mentioned her in my next article for
MPhA. She was surprised and blushed a little. But I believe she, as
well as all of you who take that extra effort, deserve to know that
the patient really does appreciate what you do.
So, like Tia, take a step around the counter and make yourself
available and approachable. They will appreciate it. I did.
Thank you, Tia!
1 “Patient perspective of medication information”, JAPhA, July/Aug
2011, pp510-519.
Dear Pharmacy Colleague,
The Minnesota Pharmacists Association is pleased to host the 5th Annual
platform/poster presentation program at the MPhA 128th Annual Meeting,
Minnesota Research and Practice Innovation Forum being held at Madden’s Resort
in Brainerd, Minn.
This venture provides an opportunity for those of us performing research or
developing innovative pharmacy services to present findings and experience to
pharmacy practitioners in Minnesota. It is an exciting opportunity for practicing
pharmacists, academic faculty, residents and students to display their work, and
to share its impact with the individuals responsible for serving the medication
needs of Minnesota’s citizens. In past years we have received excellent examples
of innovation and research in pharmacy; and we hope that more pharmacists
and students will participate this year.
The platform presentation program will be held on Saturday, June 9, 2012,
from 10:00 a.m. to 11:00 a.m. as part of the MPhA continuing pharmacy
education. The posters will be displayed in the Exhibit Hall from 12:00 noon
to 1:30 p.m. immediately following the Oral Abstract presentations.
You are strongly invited/encouraged to submit an abstract of your work using
the form on page 22. Please indicate if you prefer platform or poster presentation format on the form. The program has capacity for four platform presentations and 24 posters. The selection committee will make the final determination.
Authors should plan a 15-minute platform presentation which includes time for
questions. Audio-visual equipment will be available [please check the appropriate
boxes on the form for audio-visual needs.] Submission deadline is Friday, April
22, 2010. Notification of acceptance and presentation format/time will be sent
via email to the address provided on the abstract by May 2, 2011 giving abstract
presenters time to prepare posters to display for the Annual Meeting.
The Minnesota Research and Practice Innovation Forum abstract form
is attached in Word format, or you can go to the Minnesota Pharmacists
Association Web site (www.mpha.org) to download the abstract form. If you
are unable to access the abstract, we can email, fax, or mail a copy to you. If you
have any questions, contact Julie Johnson at the MPhA office at [email protected]
or 651-290-7486.
Please encourage students and colleagues working on projects with application
to any aspect of pharmacy practice/administration/management to submit an
abstract for presentation at the Conference.
Upcoming Events
Visit www.mpha.org
for more information
128th Annual Meeting,
June 8-10, 2012
Madden’s Resort, Brainerd
HerbIe Cup Golf Invitational,
June 8, 2012
Madden’s Resort, Brainerd
Pharmacy Technician
Conference
MSHP/MPhA Event,
July 19, 2012
Crowne Plaza, Plymouth
FAll Clinical Symposium,
September 16, 2012
Crowne Plaza, Plymouth
fall mtm symposium,
November 16, 2012
DoubleTree Hotel, Bloomington
Sincerely,
Scott Setzepfandt, RPh
MPhA President
Moved, graduated, or have a name change?
Update your profile
through your online
MPhA Member Portal page.
Minnesota
Minnesota
Pharmacist
Pharmacist
Winter
Winter
20122012 5
n
n
executive’s report
Remembering The Dream Weaver
by Julie K. Johnson, PharmD, MPhA Executive Vice President/CEO
My classmates at the University of Minnesota Class of 1981
called him “Dream Weaver.” My memory from College of
Pharmacy days blurs a little — but here is my perception of that
time:
Classes were challenging. The curriculum seemed to be forever
changing. The question of the day was, “should I go on to get
my PharmD?” Did I mention the classes were challenging? The
thought (to me) of spending two more years working/studying/
working/studying/taking tests/working did not appeal to me at
all. No one could convince me that more education was going
to prepare me to land a better job any faster than I would graduating with a BS in pharmacy in 1981 from one of the highest
ranked colleges in the country. I had a plan. Graduate, get out,
get a job, don’t look back — and for heaven’s sake, don’t go
back.
Your dreams live on in all of us, Larry. Thank you for the things
you gave to us. You have paid it forward for a very long time.
Julie K. Johnson, PharmD
MPhA Executive Vice President/CEO
Does this sound at all familiar to anyone? Do things change as
much as they stay the same?
Larry Weaver led the growth of the profession of pharmacy
throughout his entire life. He pushed to improve curricula, build
buildings, and move the College of Pharmacy into the health sciences complex from its original home in riverside Appleby Hall.
I did go back, like many of you. Back to the College of Pharmacy
to be a preceptor, to be a mentor, to deliver a lecture and to teach
classes. I joined the association after graduation because someone
made me. I joined the staff of the College on a part-time basis for
12 years. I joined the MPhA in 2001.
I returned to complete my PharmD in 2006, long after Larry
Weaver “retired.” My perceptions changed as years passed. His
effect on me, and everyone he knew, was profound. No one person directly influences one other person all on his or her own.
But the tapestry of positive influence created by the lifelong contributions of people like Larry Weaver will forever exist.
He dreamed big and never, ever, ever gave up. He was dean in
the ‘80s and then again later, when he was needed in that position again. WHAT? Who would do that? Nobody is dean twice.
He was present at every pharmacy function I can remember. Big
as life with his life partner always at his side. Kind, soft spoken,
a small-statured giant. Larry was my dean. I did not know what
that meant in the ‘80s. I know now.
n
7
viewpoint
Walgreens: “America’s premier
pharmacy” lives up to its
self-image
1
by Lowell J. Anderson, DSc, FAPhA
This is a pat on the back for Walgreens for its public and professional leadership.
It is not about Express Scripts (ESI) — ESI is just doing what
PBMs normally do.
Walgreens has chosen to reject the contract offered by
Express Scripts and removed itself from the Express Scripts
network by January 1, 2012.
I have no idea what the dollars are in the negotiation. It really
doesn’t matter to me, because it is not so much the why as
it is the how. Walgreens effectively told the world that there
was a reimbursement even they could not accept. They have
managed to save some contracts because of the relationships
and contracts with employers. By the time this is printed they
may have even have come to terms with ESI.
with independents, where (in Minnesota) there is a whole
generation of pharmacists who have not experienced the
thrill of having a PBM increase a dispensing fee.
As partial justification for its action, Walgreens cites pharmacy
services that are currently not compensated.
With growth in prescription-drug sales slowing, Walgreens
and other major retail pharmacy chains hope to boost revenue by offering new health-care services. In addition to filling
prescriptions, they now help patients manage their medications. For example, Walgreens pharmacists advise customers on appropriate doses and try to switch them to cheaper
generic alternatives when possible.
“Our product is not a pill; our product is a health outcome,”
says Walgreens Chief Executive Greg Wasson.
In the meantime, it will have caused concern or inconvenienced a lot of Walgreens customers. But those several millions might just get a feel for the economic facts of life in the
prescription business. The company’s stock is down 30% since
they announced the disagreement in June. That is a lot of
money — so even the investor community might understand.
Express Scripts’ response thus far: A pill’s a pill, and Walgreens
doesn’t deserve more money than other pharmacies for telling
patients how to take them. If Express Scripts did agree to pay
more, Walgreens would become its most expensive pharmacy, raising client costs “for essentially doing the same thing as everyone
else,” says spokesman Brian Henry.2
I know that contrary to conventional wisdom, chains do reject
contracts for a variety of reasons. We rarely hear of these
rejections because it is good business to keep contract negotiations close. They usually do not broadcast these decisions
to either the public or broadly to the profession.
Re-read that Express Script response — it is telling! Mr.
Henry’s assertion that “A pill’s a pill” clearly reflects a philosophy that a prescription medication is merely a product that
requires distribution. Evidently ESI has little corporate concern
about whether or not the “pill” achieves the desired outcome
— the outcome that its employer customer is paying for.
Pharmacists in independent practice understand that they
have little bargaining clout when it comes to negotiating contracts with pharmacy benefit managers and managed-care
organizations. In spite of the often-repeated assertions by
these organizations that contracts are negotiated, the independents are usually told to “take it or leave it,” should they
try to negotiate. More often than not, to “leave it” is not an
option for the independent and smaller chains.
The chains, however, may negotiate with some degree of
success because the PBMs and MCOs need their distribution
channels; and one negotiation may result in several thousand
outlets. I suspect that many of the chain/PBM contracts have
even kept pace with the rising costs of dispensing even if not
fully recovering dispensing costs. Certainly that is not the case
8
n
On the plus side, Mr. Henry does recognize that “everyone
else” does provide information. Of course they don’t pay
“everyone else” either.
I imagine that this was a much-researched decision by
Walgreens as there are very real costs and market considerations. I have no doubt that Walgreens assessment was
that signing the offered contract would not be a financially
responsible and defensible decision. Ultimately, they must
answer to the Walgreens’ stockholders.
Mr. Wasson, Walgreens CEO, said in an analyst conference
call: “The terms Express Scripts offered us, including rates that
were below the industry average cost to provide the prescription,
were not in the best interest of our company, our customers, our
employees or our shareholders.”3
of our company, our customers, our employees or our shareholders”?
ESI is in a sticky spot here also. If it does agree to a contract
with Walgreens that assigns a value for what “everyone does
for free” it will provide an opportunity for other pharmacy
providers to seek similar treatment that recognizes the value
of pharmacists’ services in their next contracts.
Personally, I commend Walgreens for its actions — both for
rejecting a contract that was not in its interests or the interests of the customers it serves, and even more important, for
bringing the issue to the professional, public and investor
communities.
Corporate courage — sometimes hard to distinguish from
tough negotiating, but still courage — is a rarely seen attribute today. I think that the pharmacists of America should
support the courage of Walgreens. When the Express Script
member transfers a prescription because of this contract
disagreement, the receiving pharmacist should talk to the
member about the importance of compensation for valuable
services and compliment Walgreens for its courage. And also
how their employer and its PBM have chosen to not pay for
these services. The Walgreens pharmacists, I hope, do likewise
when their patients ask about the contract.
Walgreens, by some estimates, may lose 10% of prescription
volume over this. Are the independents and other chains
prepared to take a stand with similar costs? Our history is that
we do not. And, of course, that is why the fee schedules are
what they are. When pharmacy owners and managers read
these contracts it should be with the same question that Mr.
Wasson addressed: are these contracts “in the best interest
Lowell J. Anderson, D.Sc., FAPhA, practiced in community pharmacy
for most of his career. He is a former president of MPhA, Mn Board
of Pharmacy and APhA. In addition he has held positions in the
Accrediting Council on Pharmacy Education, National Association of
Board of Pharmacy and the United States Pharmacopeia. Currently
he is Co-director of the Center for Leading Healthcare Change,
University of Minnesota and co-editor of the International Pharmacy
Journal. He is a Remington Medalist.
1 Walgreens Web site
2 “Walgreens seeks payment for customer counseling in Express Scripts
battle”, The Wall Street Journal, 25 October 2011
3 Medill Reports, Shaina Humphries, 15 November 2011
n
9
feature
Drug dosing based on kidney function:
a survey of minnesota pharmacists
By Kenzie G. Hohman, PharmD Candidate, and Wendy St. Peter, PharmD, BCPS, FASN, FCCP
Drug dosage adjustment based on kidney function is a standard of practice in some ambulatory and most acute care settings as impairment
of kidney function alters the pharmacokinetics of
several medications. Dose modifications based on
kidney function are made to improve therapeutic
outcomes and minimize adverse effects or toxicity. Direct measurement of the glomerular filtration
rate (GFR), using an exogenous marker such as
inulin, is the most accurate method to measure kidney function, but is difficult, time-consuming, and
expensive.2,12,18 There are several other methods
to estimate kidney function and method utilization
varies between practitioners.1-3,8,16 This creates a
challenge in determining the optimal dosing regimen.
To facilitate in the detection of CKD, the National Kidney Disease
Education Program (NKDEP) strongly encourages laboratories to
routinely report estimated GFR values when serum creatinine values
are measured in patients 18 years or older.11 The availability of the
eGFR in laboratory reports may result in confusion among health
professionals on whether or not to use reported eGFR results to
dose medications. Up to this point, there have been no prospective
pharmacokinetic studies that have utilized eGFR results to create
drug dosing recommendations.
The U.S. Food and Drug Administration’s (FDA) guidance document for kidney impairment, published in 1998, recommends that
pharmaceutical companies use the Cockcroft-Gault (C-G) equation
to estimate kidney function.5 Thus, most medications’ renal drug
dosing guidelines have been developed using the C-G equation as
the basis for estimating kidney function. A variety of body weights
including actual body weight, ideal body weight, adjusted body
weight, or lean body weight are utilized for the weight parameter
within the C-G equation. Also, for serum creatinine values less than
1 mg/dL, some practitioners may round up to 1 mg/dL, or another
value, depending on patient parameters (i.e. weight or age).
To add to the clinical conundrum, the NKDEP has recommended
that creatinine assay manufacturers incorporate assay calibration
standards.10,11 To date, the majority of clinical laboratories are
using standardized creatinine assays.11 Creatinine assay calibration
standardization reduces variation of serum creatinine measurement
between laboratories. Although standardization provides more
consistent serum creatinine values, the values are slightly lower,
on average, than those before creatinine standardization.10,21 Most
drugs’ labeling were developed prior to standardized calibration
of creatinine assays. This has made assessing kidney function for
the purpose of drug dosing adjustment more complex. Thus, it is
important to determine how pharmacists in Minnesota are assessing
kidney function for the purpose of drug dosage adjustment.
Methods:
A cross-sectional survey was distributed to pharmacist members of
the Minnesota Pharmacists Association (MPhA) and the Minnesota
Society of Health System Pharmacists (MSHP). The 13-item questionnaire was created and administered through a Web-based survey
program, SurveyMonkey. The University of Minnesota institutional
review board approved the survey and overall research plan.
Members of MPhA were reached through the January CAPS newsletter. MSHP’s members were invited to participate through an
email sent in December 2010.
The questionnaire addressed the following: equation(s) used to
estimate kidney function for drug dosage adjustment, body weight
choice for the C-G equation, adjustment of serum creatinine values
based on age, and knowledge of eGFR reporting and serum creatinine standardization. Demographic information on responding
pharmacists was also collected.
Results:
The survey was sent to a total of 1110 pharmacists, 367 pharmacists in MSHP and 743 pharmacists in MPhA. 164 pharmacists
completed the survey for a response rate of 15%; however the number of dual members is not known, thus the response rate may be
higher.
Most of the pharmacists who responded to the survey worked in the
hospital setting and about half of all respondents were under age
40. In addition, 68% had a PharmD degree and 41% had residency
training.
Most pharmacists used the C-G equation (99%) while only 14%
reported using Jelliffe, 13% MDRD, 10% Salazar-Corcoran, and
6% Modified-Jelliffe at some time in their practice setting (Figure
1).
Pharmacists reported using a variety of weight parameters and
Kidney Function continued on page 11
Kidney Function continued from page 10
adjusting the serum creatinine value in the C-G equation given
various patient scenarios. A summary of the various methods can
be found in Figures 2-3. In obese patients, 86% reported using
adjusted body weight and 64% reported using ideal body weight,
either all or some of the time. In non-obese patients, 80% reported
using actual body weight and 82% reported using ideal body
weight, either all or some of the time. Values of serum creatinine
less than 1 mg/dL were reported to be adjusted to 1 mg/dL (or
another value) by 62% of pharmacists. Of the pharmacists who
adjust serum creatinine values when the reported value is less than
1 mg/dL, 53% reported making this adjustment at a certain age
cutoff. A variety of age cutoffs were reported with age 65 appearing
most frequently.
58% of pharmacists were unsure if their institution was utilizing a standardized serum creatinine assay. 86% of pharmacists
were aware of their institution’s reporting of automated eGFRs;
75% of pharmacists indicated their institution did report and
11% indicated their institution did not report eGFR values.
Discussion:
Providing optimal medication therapy is often dependent
upon estimating a patient’s kidney function. Overestimating
kidney function may result in drug toxicity, while underestimating kidney function may lead to subtherapeutic dosing
and treatment failure.
Several equations exist to determine drug dosing in patients with
impaired kidney function; however, none of the equations are perfect. The C-G equation was developed in 1976 to estimate CrCl
and is used as a rough estimate of GFR.2 The majority of kidney
drug dosage adjustments have been determined using CrCl and the
C-G equation as the standard. The MDRD 4-variable equation
was originally developed in 1999. It has been shown to be more
accurate than the C-G in estimating GFR.8,11 However, it is not
very accurate in individuals with a GFR > 60 mL/min/1.73m2.
The MDRD 4-variable equation was re-expressed for use with standardized serum creatinine values. The newer CKD-EPI equation
was developed for use with standardized serum creatinine and is
more accurate than the MDRD equation in patients with GFR>60
mL/min/1.73m2. The C-G equation cannot be re-expressed for
standardized creatinine because the creatinine method used in the
development of the equation is no longer in use and samples from
the study are no longer available.12 All of these equations are limited by the use of creatinine as a filtration marker. The serum level
of creatinine is determined by factors other than the GFR, such as
kidney tubular secretion, diet, and muscle mass. The MDRD and
CKD-EPI equations more accurately estimate GFR than C-G and
are used to stage chronic kidney disease.11 However, as noted previously, most dosing recommendations were not based on measured
or estimated GFR but rather estimated CrCl.5
Based on our survey results, C-G was the equation predominantly
used by Minnesota pharmacists for drug dosage adjustment in
patients with kidney dysfunction. Use of the C-G equation is
consistent with the FDA’s current recommendation for pharmaceutical companies.5 However, the FDA has recently issued an
updated draft guidance document for kidney impairment that
recommends use of both MDRD for eGFR and C-G for eCrCl.
Final recommendations have not been published.6 The Nephrology
Practice and Research Network of the American College of Clinical
Pharmacy (ACCP) also recommends estimating kidney function
using both the C-G equation and an appropriate GFR estimating
equation. The re-expressed MDRD or CKD EPI equation should
be utilized if the laboratory uses a calibrated serum creatinine assay.
If suggested drug dosage adjustments differ based on results from
each equation, the clinician should consider the clinical scenario,
evaluate the risk-benefit ratio of potential under- versus overdosing,
and use clinical judgment to determine whether the higher or lower
dose may be more appropriate as the initial dose in that individual
patient.13
There was significant variability in the choice of weight used
in the C-G equation (i.e. ideal versus actual or adjusted body
weight). Based on our survey, Minnesota pharmacists are
consistent in that few pharmacists use actual body weight for
obese patients. Results were much more variable between the
use of adjusted body weight and ideal body weight in obese
patients. Similarly, for non-obese patients, only 2% reported
always using adjusted body weight but many pharmacists
used actual or ideal body weight. Use of various weight
parameters in the C-G equation increases the variability in
results from one practice to another.
A recent article by Pai reviews the most appropriate weight parameters to use in obese patients when using C-G or eGFR equations,
such as MDRD or CKD-EPI. Evidence supports use of total body
weight (aka actual body weight) in the C-G equation unless the
patient is obese (BMI >30). In obese patients, lean body weight
(LBW2005-Figure 4) is a better weight parameter to use than
ideal body weight. For eGFR equations, multiply the eGFR by the
patient’s BSA, using the Mosteller BSA method (Figure 4).14 Of
note, using the Mostellar BSA adjustment method can greatly overestimate eGFR in morbidly obese patients. The ACCP Nephrology
Practice and Research Network also supports use of lean body
weight in the C-G equation for obese patients.13 Unfortunately,
our survey did not specifically query about the use of lean body
weight in the C-G equation in obese patients.
In 2005, the NKDEP initiated a creatinine standardization program to reduce interlaboratory variation in creatinine assay calibration.11,19 Prior to creatinine standardization, variation in creatinine
assays resulted in inconsistent creatinine values and thus potentially
inconsistent drug dosing recommendations. Most clinical laboratories are now utilizing creatinine assays that have calibration
traceable to an isotope dilution mass spectrometry (IDMS) reference. Assay calibration yields more consistent but slightly lower
serum creatinine values, on average, than the values yielded prior to
implementation of standardized creatinine.21 Lower serum creatinine values result in a higher eCrCl calculation that may result in
a higher recommended dose as compared to the timeframe before
creatinine standardization. A majority of Minnesota pharmacists,
approximately 58%, were unaware of whether or not serum creatinine values from their clinical laboratory were standardized. More
education is needed, as pharmacists should understand the implications of using standardized creatinine values.
n
11
Conclusions:
Appropriately assessing kidney function is imperative to properly dose drugs eliminated by the kidneys. The C-G equation
is predominantly used by Minnesota pharmacists to estimate
kidney function for drug dosing purposes. But creatinine assay
standardization presents additional challenges when interpreting
C-G results. Pharmacists need to understand the implications of
standardized creatinine values and weight parameters on the variability of CrCl results when using C-G for drug dosing in patients
with reduced kidney function, especially with narrow therapeutic
index drugs and in critically ill patients. A standardized approach
to drug dosage adjustment in patients with stable kidney function,
as suggested by the ACCP Nephrology Practice Research Network,
will help reduce variability in drug dosing adjustments from one
practice to another.
Figure 4: Weight Parameter Adjustments for use in Estimating
CrCl and GFR for Drug Dosage Adjustment in Obese Patients
References:
1 Bouchard J, Macedo E, Soroko S, et al. Comparisons of methods for
estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transplant. 2010; 25:102-107.
2 Cockcroft DW, Gault MH. Prediction of creatinine clearance from
serum creatinine. Nephron. 1976; 16:31-41.
3 Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in
morbidly obese patients. Am J Health-Syst Pharm. 2009; 66:642-648.
4 Dowling T, Matzke G, Murphy J, Burckart G. Evaluation of renal
drug dosing: prescribing information and clinical pharmacist approaches.
Pharmacotherapy. 2010; 30(8):776-786.
5 Food and Drug Administration. Guidance for Industry: Pharmacokinetics
in Patients with Impaired Renal Function — Study Design, Data
Analysis, and Impact on Dosing and Labeling. Department of Health
and Human Services; May 1998. http://www.fda.gov/Drugs/
GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm.
6 Food and Drug Administration. Guidance for Industry: Pharmacokinetics
in Patients with Impaired Renal Function — Study Design, Data Analysis,
and Impact on Dosing and Labeling (Draft Guidance). Department of
Health and Human Services; March 2010. http://www.fda.gov/Drugs/
GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm.
7 Hermsen ED, Maiefski M, Florescu MC, et al. Comparison of the
Modification of Diet in Renal Disease and Cockcroft-Gault Equations for
Dosing Antimicrobials. Pharmacotherapy. 2009; 29(6):649-655.
8 Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the
Modification of Diet in Renal Disease Study Group. A more accurate
method to estimate glomerular filtration rate from serum creatinine: a new
prediction equation. Ann Intern Med. 1999; 130:461-70.
9 Moranville M, Jennings H. Implications of using modification of diet
in renal disease versus Cockcroft-Gault equations for renal dosing adjustments. Am J Health-Syst Pharm. 2009; 66(2):154-161.
10 Myers G, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working
Group of the National Kidney Disease Education Program. Clin Chem.
2006; 52(1):5-18.
12
n
4 Fraud and Abu
se Training
4 Pseudoephed
rine Log
4 OSHA Requ
irements
4 HIPAA Priva
Policies an cy and Security
d Procedur
es
Quality As
Program surance (QA)
Is a QA Program Missing From Your Checklist?
Pharmacy Quality Commitment™ (PQC™) is what you need!
Reduction of medication errors and implementation of a QA program are no longer options. A growing
number of pharmacy network contracts require a process in place and no matter what it is called, QA, CQI,
safe medication practices, or medication error identification and reduction program – PQC™ is the answer.
•
•
•
•
•
•
The PQC™ Program:
Legally protects reported data through a federally listed Patient Safety Organization (PSO)
Helps increase efficiency and improve patient safety through a continuous quality
improvement (CQI) process
Provides easy-to-use tools to collect and analyze medication near miss and error data
Presents a turnkey program to help you meet obligations for QA and CQI requirements
Includes simple method to verify compliance
Offers excellent training, customer service and ongoing support
Not all programs are the same, make sure your pharmacy and your data is protected. Pharmacies that license PQC™ and
report patient safety events are provided federal legal protection to information that is reported through the Alliance for Patient
Medication Safety (APMS) – a federally listed PSO. To learn more about PSOs, visit www.pso.ahrq-gov/psos/fastfacts.htm.
TM
Call toll free (866) 365-7472 or go to
www.pqc.net for more information.
PQC is brought to you by your state pharmacy association.
n
13
feature
MN PhARMACY
Minnesota Practice-Based
Research Network: An
Update
By Rita Tonkinson
Minnesota’s pharmacy practice-based research network
(PBRN) was introduced about
five years ago to pharmacists
in the November/December
2007 issue of the Minnesota
Pharmacist. It was formally
launched in February 2008. Since the initial article, little has been
reported in this publication. It’s time to focus attention on the
progress of the network, and encourage Minnesota’s pharmacists to
review the programs, take a look at the opportunities, and consider
the options.
PRACTICE BASED
RESEARCH NETWORK
The PBRN was announced by Jon Schommer, PhD, RPh, professor, University of Minnesota College of Pharmacy, in the above
mentioned article. A few Minnesota Pharmacist readers may not
recall the article; others may have lost track of the network’s progress. Following is a brief history, followed by an update. Much
of this recap is taken from Schommer’s 2007 article and from
the white paper written in May 2010 with Schommer as the lead
author. The white paper was also supported by a distinguished
advisory/review board of pharmacists, national association leaders and academic pharmacy leaders. The paper “Establishing
Pharmacists Practice-Based Research Network, an American
Pharmacists Association (APhA) Foundation White Paper,”
describes the process of looking at more than “two decades of success for PBRNs in primary care practice and the coincident evolution of community pharmacy practice as a recognized patient access
point.” In the paper, Schommer cites the point that medications are
used by almost all members of society and pharmacists are accessible providers of medications to the public. The paper clearly defines
the process leading up to the launch in Minnesota.
In the Executive Summary, Schommer described what he called a
“Research Gap Analysis.” He said that “leaders within the APhA
Community Pharmacy Residency Program (CPRP) began discussions regarding the creation of a Practice-Based Research Network
using CPRP sites (named PBRNet). To begin dialogue for this
idea, 15 individuals who were affiliated with community pharmacy
residency programs convened to participate in a focus group on
April 5, 2009 in San Antonio, Texas. The purpose of this inquiry
was to understand the most important elements needed for an
infrastructure to support a PBRNet.”
To understand the scope of a PBRN, the nationally accepted definition of a practice-based research network is helpful. Schommer
describes a PBRN as “a group of ambulatory practices devoted
principally to the primary care of patients, affiliated with each other
(and often with an academic or professional organization) in order
14
n
to investigate questions related to community based practice.”
During the last few months of 2007, the Minnesota Pharmacists
Association (MPhA) and the University of Minnesota College of
Pharmacy developed a Minnesota Pharmacy PBRN, introducing
the concept at MPhA’s Pharmacy Nights that fall. At that time,
30 pharmacies were enrolled. In order to be considered a PBRN
by national funding agencies, at least 15 practice sites are required.
Beginning in March of 2009, grant proposals were submitted for
funding. Requirements for consideration by a funding agency
included in the grant competitions are: 1) a “network capacity”
consisting of pharmacies willing and able to collaborate on projects
and 2) an infrastructure for managing the projects.
The two organizations have developed a PBRN “Capacity
Portfolio,” a document for internal use and to be submitted to
funding agencies as part of Minnesota PBRN proposals. This is
a dynamic document, expanding to reflect the developing PBRN
network.
The building blocks of a PBRN included a sponsoring organization, community pharmacy residency program accreditation
requirements in place and the development of technology standards. In his paper, Schommer described results of a survey of the
Community Pharmacy Residency Program members (November
2009) that revealed some barriers to securing finding for conducting practice-based research. These perceived barriers included access
to electronic medical records and lack of resources/time, and experience of securing funding. The next step was developing an infrastructure: 1) director, 2) coordinator, 3) one-way communication,
4) two-way communication, 5) membership roster, 6) meetings, 7)
board, and 8) human subjects’ protection management. Schommer
also described other infrastructure elements that might be necessary,
such as 1) research assistants, 2) information technology, 3) regulatory compliance, or 4) research consulting expertise.
To this end, PBRNs can use an academic institution’s resources
already in place as partners, where research, grant writing, data
management, one- and two-way communications and other expertise are available. The ultimate goal, of course, is to translate the
research findings into practice, i.e. enhance patient care and underscore the importance of accessibility to pharmacists’ care.
The Minnesota Pharmacists Association reported that as of
December 2009, 305 pharmacy practice locations were part of the
Minnesota PBRN. Among those practice sites were: 1) communitybased pharmacies, 2) hospital-based pharmacies, 3) communitybased clinics, and 4) one investigational drug service (not available
to the general public). All but six of the PBRN pharmacies dispense
PBRN Update continued on page 15
PBRN Update continued from page 14
medication to the public. An array of PBRN research collaborations can include, but are not limited to, patient screening, education, referral, continuity of care, and follow-up as well as drug
regimen review, patient outcomes and data retrieval.
In its ongoing role as a valuable resource for its members and for
the public, MPhA has further enhanced its role in disseminating
PBRN network information on its Web site and through other
communications with its members. Julie K. Johnson, PharmD,
executive vice president and CEO, MPhA, served in an advisory
capacity in the beginning of the PBRN program and continues
to serve in various ways as the network continues to develop. If
you wish to view the current list of PBRN projects and locate the
map of PBRN locations, visit: http://www.mpha.org/associations/9746/files/PBRN/index.html.
“Dr. Schommer has called participating in such a network as collecting information in real-world settings to help address societal,
community, or professional questions that relate to medication
use,” said Johnson. “Based on feedback from individual pharmacists involved in the PBRN, while continuing to provide expanded patient services and promote the value of pharmacists in the
health care community, many have said they have enhanced their
professional and personal experience.”
During 2011, Schommer said in a communication on the status
of PBRN, there were ongoing preparations for funding project proposals. There is also a listing of papers covering current
practice-based research on the College of Pharmacy Web site,
Innovations in Pharmacy. Visit this site for additional important
information: http://www.pharmacy.umn.edu/innovations/pbresearch/home html
In the same communication Schommer described goals for 2012:
“Our goals for 2012 are to continue preparing project proposals
and to complete funded projects. We are nearing the point in our
development as a PBRN where we can discuss the types of projects for which we have achieved the greatest success and consider
ways to invest in those areas. Our PBRN is beginning to establish
an identity, and we can consider ways to build upon that foundation. One challenge is to anticipate how our capabilities and
capacities can fit into the opportunities that are still emerging.”
11 National Kidney Disease Education Program. Laboratory Professionals:
Creatinine Standardization and Estimating & Reporting GFR. Available
online at: http://www.nkdep.nih.gov.floyd.lib.umn.edu/labprofessionals/
index.htm.
12 National Kidney Disease Education Program. Chronic Kidney Disease
and Drug Dosing: Information for Providers (Revised January 2010).
Available online at: http://www.nkdep.nih.gov/professionals/drug-dosing-information.htm.
13 Nyman HA, Dowling TC, et al. Use of the Cockcroft-Gault versus MDRD Study Equation to Dose Medications: An Opinion of the
Nephrology Practice and Research Network of the American College of
Clinical Pharmacy. Pharmacotherapy. 2011.
14 Pai MP. Estimating the glomerular filtration rate in obese adult
patients for drug dosing. Advances in Chronic Kidney Disease. 2010;
17(5): e53-e62.
15 Prigent A. Monitoring renal function and limitations of renal function tests. Semin Nucl Med. 2008; 38(1):32-46.
16 Salazar DE, Corcoran GB. Predicting creatinine clearance and renal
drug clearance in obese patients from estimated fat-free body mass. Am J
Med. 1988; 84:1053-60.
17 Siew E, Matheny M, Ikizler TA, et al. Commonly used surrogates
for baseline renal function affect the classification and prognosis of acute
kidney injury. Kidney Int. 2010; 77(6):536-42.
18 Stevens L, Nolin T, Richardson M, et al. Comparison of drug dosing
recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009; 54(1):33-42.
19 Stevens L, Stoycheff N. Standardization of serum creatinine and
estimated GFR in the Kidney Early Evaluation Program (KEEP). Am J
Kidney Dis. 2008; 51(4):S77-S82.
20 Verbeeck RK, Musuamba FT. Pharmacokinetic and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009;
65:757-773.
21 Wade W, Spruill W. New serum creatinine assay standardization:
implications for drug dosing. Ann Pharmacother. 2007; 41(3):475-480.
As of February 2012, the Minnesota PBRN consisted of 366
geographically dispersed pharmacies and 23 principal investigators from the University of Minnesota (See Appendix D of Dr.
Schommer’s most recent summary on MPhA’s Web site). A
summary of projects that have utilized the Minnesota Pharmacy
PBRN can be found in Appendix E of the same document
entitled, “The Minnesota Pharmacy Practice-Based Research
Network.”
Review the complete text of the white paper, “Establishing
Pharmacists Practice-Based Research Network, an American
Pharmacist Association Foundation White Paper,” by following the link: http://www.pharmacist.com/AM/Template.
cfm?Section=Professional_Advancement&Template=/CM/
ContentDispaly.cfm&ContenID=23805
Rita Tonkinson is a contracted staff writer for the association, who
provides insightful looks into the field of pharmacy for our readers.
n
15
PHARMACY MARKETING GROUP, INC. • PHARMACY and the law
recordkeeping isn’t
that important, is it?
by Don McGuire, RPh, JD
This series, Pharmacy and the Law, is presented by Pharmacists
Mutual Insurance Company and your State Pharmacy Association
through Pharmacy Marketing Group, Inc., a company dedicated to
providing quality products and services to the pharmacy community.
Terry at Midtown Pharmacy was dealing with another recurring
frustration. The pharmacy’s usual generic brand of atenolol was
backordered again. Terry ordered a couple of 100 count bottles
to hold them over until the usual brand was available again. Terry
didn’t bother to update the computer database to reflect this
change because she would then just have to change it back again
two days from now. The change isn’t really that important anyway, right?
Wrong. Your documentation is the only thing you will have
later to prove what you did today. We all forget things, especially when they come up weeks or months later. Consider the
following claim scenario.
A pharmacy was sued by a former patient over some faulty
transdermal fentanyl patches. The patient alleged that he was
injured due to the patch releasing the medication too quickly.
The patient’s profile indicated that he received the patch
manufactured by company A. Company A’s product had, in
fact, been recalled due to this very problem. The patient was
sure that the excessive dose delivered had caused him to
be hospitalized. The pharmacy staff went through months
of anxiety and expense while producing records and being
deposed. What everyone learned at the end was that the
patch received by the patient wasn’t manufactured by company A. He had received patches manufactured by company
B. This was discovered when reviewing the invoices from
the time period in question. Company B’s product had been
purchased because of the recall of company A’s patches.
However, the patient profile indicated that the patient had
received Company A’s patches. Proper recordkeeping would
most likely have prevented this pharmacy from suffering
through months of litigation.
A second consideration here is billing. In today’s world, it is
more important than ever to bill for what was actually dispensed.
Third-party payers expect and demand that their customers
receive the product that is billed to the third-party payer. While
the two different fentanyl patches discussed above may be clinically interchangeable, they are probably not the same when it
16
n
comes to acquisition
cost or reimbursement
In litigation, documentation
rates. One may have
been non-formulary,
is everything. If it wasn’t
for example. This difference is multiplied if
documented, it wasn’t
one product is the brand
name one. Clinically,
done. Many cases have
none of the differences
are significant. However, turned on seemingly small
we aren’t talking about
therapeutics. We are
documentation issues.
talking finances and
recordkeeping. This sort
of discrepancy can lead to repayment demands, even penalties and
interest, following an audit.
The importance of recordkeeping shouldn’t be overlooked.
In litigation, documentation is everything. If it wasn’t documented, it wasn’t done. Many cases have turned on seemingly small documentation issues. Perpetual inventory totals,
timecards, delivery records, pick-up logs, documentation of
counseling (or refusal of counseling) are some other examples
of records that have become key points in a case. The lesson
here is that no record is too small or too trivial to be skipped
over. Update those inventory changes as they come in. It may
seem burdensome at the time, but there are potential benefits later.
© Don R. McGuire Jr., RPh, JD, is General Counsel at Pharmacists
Mutual Insurance Company.
This article discusses general principles of law and risk management. It is not intended as legal advice. Pharmacists should consult
their own attorneys and insurance companies for specific advice.
Pharmacists should be familiar with policies and procedures of their
employers and insurance companies, and act accordingly.
A Buying group for independent retAil phArmAcies
...owned by 19 state pharmacy organizations
...a leader negotiating on behalf of independents
...saving pharmacies money for more than 25 years
...financially supports the state pharmacy organizations
...serving pharmacies nationwide
1-888-200-0998 | www.pacealliance.com
n
17
Student Perspective
Home care:
A new frontier for pharmacy practice
Delford Ilara Doherty, PharmD and MPH Candidate, 2010; University of Minnesota College of Pharmacy and School
of Public Health
With millions of baby boomers retiring and turning to Medicare
for their health insurance needs, many in the health care industry
are looking to combat rising health care costs in order to sustain
this program. Pharmacists are well-trained and well-positioned to
play an integral role in Medicare cost containment. The model
for pharmacist involvement in health care already exists in current
programs such as medication therapy management (MTM). The
most promising frontier for pharmacists in the rapidly changing
health care landscape is home health care-based MTM.
A valuable opportunity
For some time, pharmacists have ceded home health care to public
health nurses who provide services to patients in their homes. My
first experience with home care MTM came on my ambulatory
care rotation with Shannon Reidt, PharmD, MPH, BCPS, at the
Minnesota Visiting Nurse Agency in Minneapolis. Before this
rotation, I had a vague perspective of home care as the territory of
nurses and public health practitioners. It soon became clear to me,
however, that home care-based MTM is a public health necessity
and one that presents a great opportunity for pharmacists.
The population of homebound seniors is growing as older patients
attempt to avoid the cost of nursing home institutionalization.
Homebound patients are missed opportunities for clinical interaction. They often have complex medical histories, take multiple
medications, have multiple prescribers, use multiple pharmacies,
have mobility problems, and lack easy access to pharmacies and
clinics that provide MTM services. These patients would greatly
benefit from MTM services, especially when delivered in conjunction with a home care agency team.
Home care has largely been provided by family care providers,
home care nurses, and other professionals who are not primarily
trained to identify, rectify, and prevent drug therapy problems.
This is a disservice to home care patients with many ramifications,
including the burden of illness, quality-of-life issues, and substantial cost to both patients and taxpayers.
Pharmacy has the opportunity to correct this problem. The pharmacy workforce is expanding rapidly and ingenuity, especially on
the part of recent graduates, will soon be a deciding factor in pharmacists’ careers. It is imperative for new practitioners to consider
opportunities in home health care.
when prescribers lack knowledge of the patient’s complete medication regimen or don’t understand how medications are used in
the home. Home health care providers also often deal with low
reimbursement rates. New practitioners facing record student loan
repayments may find this a serious obstacle.
However, it’s too soon to dismiss home health care-based MTM.
The passage of health care reform and emphasis on preventative
care are likely to open up exciting possibilities for pharmacy practice. I believe home care will emerge as a leading practice in providing preventative care to America’s aging population.
This is an opportune time for new practitioners to use ingenuity
to position themselves for this emerging practice in settings such as
home infusion clinics, long-term care facilities, MTM clinics, and
others. Pharmacists should also consider developing models and
mechanisms to partner with home care providers, managed care
organizations, insurance agencies, and private and public health
systems.
Determining patient needs
There is a pressing need for pharmacists to practice home carebased MTM. Being in a patient’s home offers the home care
pharmacist the opportunity to evaluate the entirety of the patient’s
circumstances, allowing for a holistic assessment of clinical needs
while considering the physical, functional, and environmental
factors affecting the patient’s health. Home care pharmacists also
have access to all medications, herbal products, and OTC products
the patient is using, as well as to caregivers who can offer their
own perspective. This kind of in-depth evaluation could not be
accomplished in the clinical setting and produces superior results,
which may prove to be the most valuable aspect of home health
care-based MTM services.
Home health care is a new frontier for pharmacists that makes it
possible for them to influence the lives of patients by preventing
disease burdens and the costs associated with drug therapy problems. Current and future practitioners should consider the possibility of a career in home care-based MTM, which could take the
form of patient care, consultation, policy, or regulation. Because
of the changing health care delivery landscape, home care-based
MTM is a moral and professional imperative.
Don’t let barriers obstruct patient care
The greatest impediment to home care practice is reimbursement.
Current home health care practitioners often must spend extensive
time coordinating patient care with multiple providers, especially
18
n
Del Doherty is a fourth-year PharmD & MPH candidate at the
University of Minnesota College of Pharmacy.
MPhA Staff
Amanda Ewald, Vice President, Finance and
Accounting. Amanda oversees all of MPhA’s financial activities including development of monthly
financial statement, paying bills, etc.
Email: [email protected]
David Ewald, President. David helps Julie
Johnson’s endeavors as appropriate to help maintain a strong relationship between staff and the
organization, and to provide assistance in seeing
that MPhA continues to make progress toward its
mission.
Jacquie Jaskowiak, Assistant Account Executive.
Jacquie assists Julie with some of the day-to-day
operational activities, and takes a strong role in
membership recruitment and retention efforts.
Bill Monn, Vice President, Member Services and
Marketing. Bill’s responsibilities include supervising the member services department, contract management and assuring appropriate resource and service levels. Bill also works with staff members and
at times directly with clients to develop strategic
business plans that promote successful and profitable operations for
client organizations.
Chris Swanson, Member Service Director. Chris
helps with events, membership and other projects.
She is one of the friendly people who answer questions when people call the MPhA office.
Anna Wrisky, Communication Specialist. Anna is
responsible for producing MPhA’s communications
including CAPS, e-News and the Minnesota
Pharmacist journal and manages the MPhA Web site.
Stay
Connected
Find us on Facebook and LinkedIn.
Minnesota Pharmacists Association
Kathie Pugaczewski, Vice President,
Communication and Technology. Kathie is
responsible for supervising the management of
communication, Web sites, webinars, developing
social media strategy and managing technology
operations.
Kelly Sprague, Meeting Planner. Kelly is responsible for assisting in the excellent execution of
MPhA’s education programs.
Laurie Pumper, Communication Director. Laurie
works with the MPhA Editorial Advisory Board to
develop content for the association’s journal and
other communication vehicles, and she assists in
providing marketing support for advertising.
n
19
MPha board of directors and volunteers
The Minnesota Pharmacists Association is
comprised of many important areas that affect
the association as a whole. Some of these
areas are elected positions (board of directors),
and others are by appointment or volunteer
(committees, task forces, etc.). All members of
MPhA are eligible to run for an elected position or participate in other areas as representatives of their setting, academy or district.
board of directors
The MPhA Board of Directors (BOD) is
comprised of elected officers and representatives who represent all pharmacy practice
settings and geographic regions in Minnesota.
The Minnesota Pharmacy Student Alliance
(MPSA), the University of Minnesota College
of Pharmacy, and the Minnesota Society of
Health-System Pharmacists (MSHP) also
sit on the MPhA board as representatives of
their respective pharmacy organizations. The
board meets bi-monthly, and is responsible
for reviewing and revising the MPhA strategic
plan and incorporating resolutions passed by
the MPhA House of Delegates.
Elections for open board positions occur
annually, with a swearing-in ceremony at the
conclusion of each MPhA Annual Meeting.
If you are interested in running for a board
position, please contact Julie Johnson at the
MPhA office.
House of Delegates
The House of Delegates (HOD) reviews recommendations and policies to go before the
Board of Directors, and is comprised of delegates from each of MPhA’s districts and academies for a full representation of pharmacy in
Minnesota. The largest HOD meeting is held
each June during the MPhA Annual Meeting.
Any MPhA member may volunteer to be
a district/academy delegate for the HOD.
Individual district and academy chairs will
determine the amount of delegate reimbursement. If you are interested in being a
delegate, please contact your chair or Julie
Johnson at the MPhA office.
academies
MPhA recognizes the diverse areas of practice
in Minnesota. Academies allow members in
the same practice setting to interact and dis-
20
n
mpha 2011/2012
board of directors
Executive/finance
Committee
PRESIDENT:
Scott Setzepfandt
Genentech
Business Phone: 952-469-5452
[email protected]
PAST PRESIDENT:
Brent J. Thompson
FirstLight Health System
[email protected]
PRESIDENT-ELECT:
Martin Erickson
Gallipot, Inc.
[email protected]
SECRETARY-TREASURER:
William Diers
United Hospitals - Inpatient
[email protected]
SPEAKER:
Meghan Kelly
[email protected]
EXECUTIVE VICE PRESIDENT:
(Ex-Officio): Julie K. Johnson
[email protected]
RURAL BOARD MEMBERs
Eric Slindee (term ends in 2013)
Witt’s Pharmacy
[email protected]
Mark Trumm (term ends in 2012)
Trumm Drug
[email protected]
METRO BOARD MEMBERs
Cheng Lo (term ends in 2013)
Phalen Family Pharmacy
[email protected]
James Marttila (term ends 2012)
Mayo Clinic
Business Phone: (507)284-8243
[email protected]
BOARD MEMBERS AT LARGE
Tim Cernohous (term ends in 2013)
University of Minnesota - Duluth
[email protected]
Tiffany Elton (term ends in 2012)
Min-No-Aya-Win Clinic Pharmacy
[email protected]
Amy Sapola (term ends in 2013)
Mayo Clinic
[email protected]
Jill Strykowski (term ends in 2013)
Allina Hospitals and Clinics
[email protected]
Jason Varin (term ends in 2013)
Cub Pharmacy - Chanhassen
[email protected]
student representation
Minneapolis
MPSA Student Liaison:
Kandace Schuft
[email protected]
DULUTH
MPSA Student Liaison:
Jeremy LeBlanc
[email protected]
Ex-Officio
Rod Carter, COP
U of M College of Pharmacy
[email protected]
Julie K. Johnson, MPhA
[email protected]
Pharmacy technician rep.
Barb Stodola
[email protected]
cuss issues important to their field. Each academy reports to
the BOD for any action needing support, as well as the HOD.
Current MPhA Academies include:
• ACADEMIC
• CHAIN MANAGEMENT
• COMMUNITY
• HOSPITAL
• INDEPENDENT OWNER
• INDUSTRY
• LONG TERM CARE
• MANAGED CARE
spring
pharmacy
nights
• medication therapy management
Save the date!
• Technician
Each academy is appointed one delegate at HOD meetings,
with one additional delegate per every additional 50 members
in the academy.
April 5 • Twin Cities
Each academy chair is responsible for setting meetings and agendas
for the academy’s members. New academy chairs are elected each
odd year by the members of the academy.
April 19 • Rochester
Members may choose to participate in multiple academies for a
nominal fee, but may only serve as a delegate for any one academy
or district per HOD meeting. Contact Julie Johnson at the MPhA
office for more information on academies.
districts
April 12 • Duluth
April 26 • Alexandria
May 9 • Brainerd
May 10 • Bemidji
committees and task forces
In order to address pharmacy issues on multiple levels, MPhA has
designated committees and task forces to review and recommend
action to the BOD. For more information on current committee
and task force opportunities, see the volunteer form on the next
page.
• Public affairs and policy development
• professional affairs
• awards
• community pharmacy business
Minnesota is divided into seven districts to allow members in each
district to network and discuss regional news and practice ideas.
• educational advisory
• Editorial Advisory Board
Each district reports to the BOD for any action needing support as well as the HOD. Each district has three delegates on
the HOD, with one additional delegate for every additional 100
members in the district.
Each district chair is responsible for setting meetings and agendas
for their members. New chairs are elected each odd year by the
members of the district.
Some districts take advantage of local Pharmacy Night meetings
to gather and discuss district business, including the election of
officers.
n
21
mpha committees and task forces
the power behind the association
The Minnesota Pharmacists Association’s committees and task forces address pharmacy issues on every level. Members of all practice
settings (including technicians and students) are needed to provide valuable insight and feedback on the workings and advancement of the
association. To become active in a committee or task force, submit the interest form located below, or contact the MPhA office for more
details. MPhA’s committees and task forces guide the association, making it as successful as it is today!
Public Affairs & Policy development committee
Educational Advisory committee
Actively engage in grassroots efforts to pursue MPhA initiatives,
monitor and react to state and federal legislation and policies.
Review and recommend new business for the MPhA Board of
Directors and House of Delegates. Meets 10x/Year.
Review and suggest educational opportunities for members that
will allow them to grow and stay current with changes in the
field. Meets 3x/Year. Committee members will participate in one of
the three planning subgroups as a non-committee member: Annual
Meeting, Fall Clinical Symposium, Midwinter, Technican Summit,
or Technician Conference.
professional affairs committee
Define and review the pharmacist’s role in the medical home.
Review health care reforms, pharmacy practice act, dispensing
compensation, and pharmacy services. Address issues related to the
pharmacist’s scope of practice and the advancement of pharmacy.
Meets 10x/Year.
Awards committee
Editorial Advisory Board
Suggest ideas for articles and/or authors. If willing, advisory board
members might write articles for the journal. Meetings are held
at the MPhA office. Meetings typically last two hours or less.
Members may use the conference call option. Meets 4x/Year.
Review and recommend changes to the MPhA award system. This
includes changes in criteria or the creation of new awards. Review
nomination forms and select award recipients. Meets 2x/Year.
Community Pharmacy Business committee
Identify and pursue initiatives to improve the community pharmacy business climate. Support pharmacy business education in
economic strategies. Develop materials to help pharmacists with provider issues. Meets 10x/Year.
Committee/task force volunteer application
The Minnesota Pharmacists Association relies on its members and pharmacy professionals to lend their time
and insight to our committees and task forces to make them successful components of our profession. The
association is continually seeking pharmacists, students, technicians and other pharmacy professionals to
become involved and be active in promoting and supporting the work of the association and making pharmacy
in Minnesota a profession worth fighting for.
Support the role
of pharmacists
in the field and
the association.
YOU can make
a difference!
We welcome your interest in serving on one of the above committees or task forces. Please submit this form by
fax or mail to the MPhA office. Sign up today and join your peers to take an active role in the perception of
pharmacy in Minnesota!
YES! I would like to serve on the following committee/task force:
________________________________________________________________________________
Name: ______________________________________________Organization:_________________________
Address: _______________________________________________ City: _______________ Zip: _________
Phone: _______________________ Fax: __________________ Email: ______________________________
22
n
association benefits
The Minnesota Pharmacists Association’s number one priority
is its members. MPhA strives to provide services and benefits to
our members that not only promote the profession of pharmacy
in Minnesota, but the professional lives of our members as well.
Ranging from advocacy and communication to discounted
professional and business programs, we are always on the search
for benefits that are valuable to you as pharmacy professionals.
Products and Services
Many of our benefits can be accessed easily through our Web
site. From online dues renewal, conference registration and member searches, we strive to not only make membership valuable,
but easy to use and navigate. Not able to find what you are looking for? Contact our office and we can help point you in the right
direction.
Business Services
• Coupon Redemption Program
• PAAS 3rd-Party Audit Services
• Credit Card Processing Services
• Pharmacists Financial Service
• Discounted AAA Automotive Membership
To access your online member benefits, use your email and personal password to login. Your MPhA Member Portal page will
allow you quick access to view your current contact information,
registered events, and invoice statements. If you forget your password, use the password link to have it reset through your email
account. Still having problems? Give us a call to confirm we have
the correct email on file.
Membership Dues:
Check with your employer to see if they cover a portion of MPhA
membership. Membership dues can be renewed online and a portion of your dues is tax deductible (consult your tax adviser with
questions). We offer a variety of options to make payment more
convenient, including a monthly debit program that will debit
your credit card, checking or savings account each month (call
the MPhA office to set up this feature).
advocacy
MPhA works to provide members with a “voice” in pharmacy
at the state and national levels. The association puts a “face on pharmacy” through media and outreach to health care entities who
rely on MPhA for information and resources related to pharmacy
services.
Through legislative representation, policy planning, and lobbying,
the association ensures that issues pertaining to pharmacy are not
overlooked or undercut. We fight for the rights of pharmacists and
pharmacy professionals to provide the highest level of care to the
patients they serve. MPhA encourages members to become involved
in this process by being active in grassroots actions and events. As
a member, you will have access to important updates and resources
made possible by your support.
Professional development and education
MPhA provides a variety of events throughout the year to keep
members involved in pharmacy issues while offering continuing
education, networking opportunities and fun! Events are listed
on the MPhA Web site and are open to all. Members receive a discount on selected event programming, such as Annual Meeting,
Fall Clinical Symposium, and Midwinter Conference.
Members benefit from discounted rates and prices on both
professional and business related services.
Professional Services
• Pharmacists Letter
• Pharmacists Mutual Insurance
• Technician Manuals
Communication
Communication is our cornerstone of keeping you informed of
association, state and national news and action.
Minnesota Pharmacist
The Minnesota Pharmacist is the association’s quarterly journal
that contains articles and features on today’s pharmacy topics,
and mails to all MPhA members.
CAPS
CAPS is our monthly faxed/emailed newsletter that keeps pharmacy professionals abreast of timely pharmacy issues and happenings. The newsletter is faxed to all pharmacies in the state, and is
emailed to all MPhA members.
E-News
E-News is our email newsletter that goes out to all subscribed
members. Monthly e-news shares upcoming events and topics,
while single e-news items may alert you to important legislative
or MPhA issues.
Pharmacy News Flash
Twice a week, Pharmacy News Flash is delivered by email to
members. These updates include news about national issues
affecting pharmacists, along with local headlines and job openings.
Career center
Tailored to both our job seekers and employers, our Career
Center allows you to browse openings or post opportunities at
your convenience. Search for Minnesota locations, or broaden
your search to outside states. The center holds a variety of
options to tailor results to your needs.
resources
Members receive special online access to pharmacy resources.
From MTM templates and brochures to information on immunizations, we save you valuable time by having these resources
readily available to you for use in your practice.
Online pharmacy education is also available through the MPhA
Web site. Home Studies and Learn Something offer a variety of
topics and timelines to fit your needs.
n
23
mpha community pharmacy defense fund
community pharmacy defense fund
The Community Pharmacy Defense Fund was established
by independent pharmacy owners and chain managers
to develop a pool of funding that could be used to fund
initiatives to move pharmacy from a position of defending the status quo to pursuing an aggressive agenda, thus
combating the growing number of threats to community
pharmacy, chief among them being:
I agree to contribute $1,000 per store.
$1,000 x _________ stores = $____________________
I wish to contribute an additional $ ____________________ to help
fund MPhA’s efforts to maintain a favorable climate for community
pharmacy.
• The inability to negotiate with third-party payers.
• Predatory pricing strategies and below-cost sales.
Name: ___________________________________________________
• The growing threat of mandatory mail-order plans
and discriminatory co-pay incentives.
Organization: ______________________________________________
• The threat of continuing cuts in pharmacy reimbursement in the public and private sectors.
City: _________________________ State: ______ Zip: ___________
• The unrelenting drive by state officials to push the
limits of personal importation of prescription drugs.
• The probable increasing difficulty for rural pharmacies
to remain viable and to transition ownership.
Contributions of $1,000 per pharmacy are dedicated to
the Community Pharmacy Defense Fund, and held in
trust by the Minnesota Pharmacists Association. The fund
is set up so that funding is directly applied to expenses
associated with specific community pharmacy initiatives.
Address: __________________________________________________
Phone: ___________________________________________________
Fax: _____________________________________________________
Payment by:
Check Mastercard
Visa
Discover
If paying by credit card, all of the following fields are required.
Card #: __________________________________ Expiration: _______
Signature: ________________________________ Sec. Code: _______
Billing Address:
Same as above
Address: __________________________________________________
City: _________________________ State: ______ Zip: ___________
Thank you to our defense fund supporters!
Those listed below contributed to the 2011 Community Pharmacy Defense Fund.
Astrup Drug
Baron’s Pharmacy
Breen’s Pharmacy
CVS
Dakota Drug
Erickson Drug
Genoa Healthcare
Goodrich Pharmacy
HealthPartners
24
n
Hennepin County Medical Center
Iverson Corner Drug
Kemper Drug
Lakes Area Pharmacy
Lewis Family Drug-Luverne
New Richland Drug
Park Nicollet Health Services
Phalen Family Pharmacy
Planned Parenthood
Scofield Drug & Gift
St Paul Corner Drug
Thrifty White Pharmacy
Trumm Drug
Walgreens
Warroad Heritage
West Seventh Pharmacy
mpha pharmacy future fund
pharmacy future fund
The Minnesota Pharmacists Association established the
Pharmacy Future Fund more than ten years ago to raise
funds that would allow MPhA to move our efforts to
support community pharmacy in Minnesota to a new
level. This fund has provided the vehicle for MPhA to
maintain full-time advocacy, to take on third-party issues,
and to address the business needs of community pharmacists.
While this program has enabled MPhA to pursue many
objectives on behalf of community pharmacy, there are
more that have been identified as priorities that we fully
intend to pursue. Our motivation to accomplish these tasks
is high, and eventually we will get there – but resources
behind motivation would enable a more rapid path to
success.
I authorize my wholesaler(s) to place a one-tenth of a percent (0.1%)
Pharmacy Future Fund contribution on my regular pharmaceutical
purchase invoices. I understand that this is a donation to the MPhA
Pharmacy Future Fund.
Name: ____________________________________________________
Pharmacy: _________________________________________________
Address: __________________________________________________
City: _________________________ State: ______ Zip: ___________
Phone: ___________________________________________________
Fax: ______________________________________________________
Signature: __________________________________ Date: _________
Thank you to our future fund supporters!
The following contributed to the 2011 Pharmacy Future Fund.
Bergh Pharmacy
Bergs Pharmacy
City Drug
Corner Drug, LeSueur
Crosstown Drug
Eagle Drug
Family Pharmacy South
Family Rexall Drug
Foley Drug
Globe Drug
Goodrich Pharmacy
Goltz Pharmacy
Guidepoint Pharmacies
Herrmann Drug
Lakes Area Pharmacy
Lake Country Drug
Moob Pharmacy
Parkers Trumm Drug
Pelican Drug
Peterson Thrifty White
Prescription Center
Pro Pharmacy #1
Pro Pharmacy #2
Ramsey Pharmacy
Range Drug
St. Paul Corner Drug
Scofield Drug
Throndset Pharmacy
Trumm Drug #1
Trumm Drug Clinic Pharmacy
Trumm Drug-Elbow Lake
Trumm Drug-Glenwood
Village Pharmacy & Gift
please support mpha to address the
needs of community pharmacy!
Choose to support the Defense Fund or the Future Fund (or both!) by returning
the information located under each fund to the MPhA office. If you have additional
questions about our pharmacy funds, please call us during normal business hours
(8:00 am to 5:00 pm) or send an email to [email protected].
Mail or fax form(s) to: Minnesota Pharmacists Association
1000 Westgate Drive, Suite 252 | St. Paul, Minnesota 55114
651.290.2266 fax
Questions? 800-451-8349 or 651-697-1771
n
25
MPha award nomination form
Please provide a letter of support for each award nominee describing in detail the reasons for the MPhA Awards Committee to consider
your nominee. Include specific examples and/or details. Attach your nomination letter and any supporting documents to this form,
including a current CV of nominee if possible. Nominations that do not include adequate information will not be considered until
missing information is submitted. Nominators will be notified when nominations are received by the MPhA office and if additional
information is required. Please see the MPhA Web site for additional award information and forms: www.mpha.org.
Harold R. Popp Award
Sponsored by MPhA, the Popp Award recognizes one pharmacist annually for outstanding services to the profession of pharmacy. This is
the highest honor bestowed by the association.
Nominee’s Name: _________________________________________ Workplace: ________________________________
bowl of hygeia award
Sponsored by Pfizer, the Bowl of Hygeia recognizes pharmacists who possess outstanding records of civic leadership in their own communities, from which their specific identification as a pharmacist reflects well on the profession.
distinguished young pharmacist award
Sponsored by Pharmacists Mutual Companies, the Distinguished Young Pharmacist Award recognizes a young pharmacist within his/
her first ten years of practice who has distinguished himself/herself in the field of pharmacy. This pharmacist is also a participant in
national pharmacy associations, professional programs, state association activities and/or community service.
excellence in Innovation award
Sponsored by Upsher-Smith Laboratories, Inc., the Excellence in Innovation Award recognizes innovative pharmacy practice resulting in
improved patient care.
Pharmacy Technician award
Presented by MPhA, the Pharmacy Technician Award recognizes a pharmacy technician in any practice setting who demonstrates leadership in their work and in their community. This includes demonstrating professionalism by participation in pharmacy association,
professional programs and/or community service, promoting teamwork within the pharmacy, providing leadership and serving as a role
model for coworkers, developing or assisting development of efficient safe procedures that support the provision of pharmaceutical care.
Recognizing
members who
are an
inspiration
to the field of
pharmacy!
Nominator’s information:
Name (please print): __________________________________________________________________________
Phone: ____________________________ E-mail: ______________________________________________
Address:_________________________________________________________________________________
City: ______________________________________________ state: _________ Zip: _________________
Please return all nominations by March 15, 2012 to the MPhA office.
26
n
n
27
7. Return abstract by:
Thurday, May 3, 2012 to the MPhA
office to [email protected] or fax:
651-290-2266
abstract, contact Todd Sorensen,
PharmD. Associate Professor, College of
Pharmacy, University of Minnesota,
[email protected]
6. If you have questions about writing an
sent to this address)
5. E-mail address of contact person
(notification of receipt and acceptance will be
4. A 4’x 8’ Velcro Board will be provided
for poster presentations. A 6’ table will
be provided only if requested by May
3, 2012. Electrical hookup is not
available for poster presentations.
(*You must bring your own laptop or a flash
drive for file transfer)
3. Visual Aids needed, if platform
 LCD projector*
2. Abstract should contain:
 Statement of purpose
 Methodology
 Results and discussion
 Conclusion
1. Entire abstract in one paragraph with no
margins. INDENT 4 spaces for first line.
No less than 10-pitch type. Stay within
borders!
Format for Abstract
 poster presentation
 to be determined by committee
* Please indicate designation of author(s), e.g., R.Ph., PharmD, etc.
Title:
Full name(s) of author(s)*, institution and address of corresponding author:
 platform presentation
MINNESOTA PHARMACISTS ASSOCIATION 128th ANNUAL CONFERENCE
June 9, 2012
ABSTRACT
Pharmacy Professionals for
Political Action
What is PharmPAC?
PharmPAC is a legal, transparent, state monitored, bi-partisan Political
Action Committee (PAC) whose major purpose is to influence the nomination or election of a candidate who supports the profession of pharmacy
and pharmacists. PharmPAC is a means to express united interests with one
powerful voice. It is power in numbers.
How does PharmPAC influence the political process?
PharmPAC solicits contributions from individual pharmacists and
pharmacy technicians in Minnesota and combines them to make larger
contributions to candidates and party units. PharmPAC funds are also used
to attend fundraiser events for candidates and party units.
Who can receive PharmPAC funds?
Candidates and incumbents who run for state office in Minnesota may
receive PharmPAC funds. House of Representative members, Senators, the
Governor, Secretary of State, Attorney General or any other state candidate
who promotes and supports pharmacy can receive PAC funds.
Which funds are accepted by PharmPAC?
Individual contributions are accepted, but corporate contributions are prohibited. For each contribution over $20.00 a record of the donor will be
kept. Anonymous contributions can not be accepted by PharmPAC. Other
political committees, political funds or political party units registered in
MN may also contribute to PharmPAC.
Is PharmPAC regulated?
PharmPAC is regulated by the Minnesota Campaign Finance Board. The
state of Minnesota has some of the most strict campaign finance laws in the
nation. All information from PharmPAC, other PACs and party units is recorded and filed with the Board. This information is available to the public
at www.cfboard.state.mn.us
Are there limits to how much a person can contribute?
An individual may contribute unlimited amounts to PharmPAC. But
PharmPAC is limited as to how much it can contribute to candidates and
party units.
How does PharmPAC determine who to contribute to?
Contributions are determined with recommendations by the Chair,
Treasurer, Deputy Treasurer, the Volunteer Committee, contributors, and
others. Contributions are given to candidates or elected officials who are
determined to be pharmacy friendly in a nonpartisan manner.
Factors used to determine “pharmacy friendly” include but are not limited
to:
• Elected officials who have sponsored or authored legislation for pharmacists or pharmacy.
• Chair persons of committees which deliberate issues relevant to pharmacy.
• Elected officials who made difficult votes in favor of pharmacy initiatives.
• Elected officials who attend or speak at pharmacy events.
• Elected officials or challengers who pledge support and demonstrate
28
n
Contributions play a significant role in electing
and supporting pharmacy friendly legislators who
understand the importance of pharmacies and
pharmacists. These legislators are willing to author
bills we need and vote for our issues in committee
meetings and in legislative sessions. PharmPAC funds
help make the Legislature as pharmacy-friendly and
pharmacy-knowledgeable as it can be.
willingness to sponsor pharmacy initiatives.
• Caucus contributions are determined based on how many candidates
or officials from the caucus attend the event, timing and effectiveness of
contribution amount.
What are the guidelines PharmPAC uses to disperse funds?
Recommendations on which candidates are made by those most involved
with the political process, ie lobbyists and PAC volunteers, Chair or Vice
Chair who lobby or have legislative and campaign experience. Contributions are disbursed in a non-partisan manner. The qualification is “pharmacy friendly” not party friendly. Persons who shall receive preference
when determining contributions, or ways to define “pharmacy friendly”:
• Elected officials who have sponsored or authored legislation for pharmacists or pharmacy.
• Chair persons of committees which deliberate issues relevant to pharmacy.
• Elected officials who made difficult votes in favor of pharmacy initiatives.
• Elected officials who attend and speak at pharmacy events.
• Elected officials or challengers who pledge support and demonstrate
willingness to sponsor pharmacy initiatives.
Why have a PAC?
PACs are an important part of the American political process. They have
been around since 1944, when the Congress of Industrial Organizations
(CIO) formed the first one to raise money for the re-election of President
Franklin D. Roosevelt. PharmPAC is another way the profession of pharmacy maintains its presence in a crowded arena of special interests in the
state’s political process.
What’s in it for me?
PharmPAC is an exciting way to be directly involved in the political
process. Being involved with PharmPAC enables you to affect your professional livelihood in a powerful, positive way. By contributing to PharmPAC
you will receive information about candidates and events in your area. You
will know who supports your professional interests at the Minnesota state
legislature. You will be a part of influencing the political process.
minnesota senators
Senate Floor ©Bill Nau
Capitol
75 Rev. Dr. Martin
Luther King Jr. Blvd.
Room (See numbers across)
St. Paul, MN 55155-1606
State Office Building
100 Rev. Dr. Martin
St. Paul, MN 55155-1206
www.senate.leg.state.mn.us
• Find your district
• Find your senator
• Learn about your senator
• Contact/email your senator
If you don’t know what district
you are in, visit the Minnesota
Senate Web site to find out who
represents you.
Name
Bakk, Thomas M.
Benson, Michelle R.
Bonoff, Terri E.
Brown, David M.
Carlson, John
Chamberlain, Roger C.
Cohen, Richard J.
Dahms, Gary H.
Daley, Theodore J. “Ted”
DeKruif, Al Dibble, D. Scott
Dziedzic, Kari Eaton, Chris A.
Fischbach, Michelle L.
Gazelka, Paul E.
Gerlach, Chris
Gimse, Joe
Goodwin, Barb J.
Hall, Dan D.
Hann, David W.
Harrington, John M.
Hayden, Jeff
Higgins, Linda
Hoffman, Gretchen M.
Howe, John
Ingebrigtsen, Bill
Jungbauer, Michael J.
Kelash, Kenneth S.
Koch, Amy T.
Kruse, Benjamin A.
Kubly, Gary W.
Langseth, Keith
Latz, Ron
Lillie, Ted H.
Limmer, Warren
Lourey, Tony
Magnus, Doug
Marty, John
McGuire, Mary Jo Metzen, James P.
Michel, Geoff
Miller, Jeremy R.
Nelson, Carla J.
Newman, Scott J. Nienow, Sean R.
Olson, Gen
Ortman, Julianne E.
Pappas, Sandra L.
Parry, Mike
Pederson, John C.
Reinert, Roger J.
Rest, Ann H.
Robling, Claire A.
Rosen, Julie A.
Saxhaug, Tom
Senjem, David H.
Sheran, Kathy
Sieben, Katie
Skoe, Rod
Sparks, Dan
Stumpf, LeRoy A.
Thompson, Dave
Tomassoni, David J.
Torres Ray, Patricia
Vandeveer, Ray
Wiger, Charles W.
Wolf, Pam
PartyDist Rm BuildingPhone Email
DFL
6
147
State
296-8881
Use Mail Form
R
49
G-24 Capitol
296-3219
[email protected]
DFL
43
133
State
296-4314
[email protected]
R
16
205
Capitol
296-8075
[email protected]
R
4
320
Capitol
296-4913
[email protected]
R
53
306
Capitol
296-1253
[email protected]
DFL
64
109
State
296-5931
Use Mail Form
R
21
111
Capitol
296-8138
[email protected]
R
38
G-24 Capitol
297-8073
[email protected]
R
25
G-24 Capitol
296-1279
[email protected]
DFL
60
115
State
296-4191
[email protected]
DFL
59
27
State
296-7809
[email protected]
DFL
46
21
State
296-8869
Use Mail Form
R
14
226
Capitol
296-2084
[email protected]
R
12
325
Capitol
296-4875
[email protected]
R
37
120
Capitol
296-4120
[email protected]
R
13
303
Capitol
296-3826
[email protected]
DFL
50
123
State
296-4334
[email protected]
R
40
325
Capitol
296-5975
[email protected]
R
42
328
Capitol
296-1749
Use Mail Form
DFL
67
17
State
296-5285
[email protected]
DFL
61
151
State
296-4261
[email protected]
DFL
58
113
State
296-9246
[email protected]
R
10
124
Capitol
296-5655
[email protected]
R
28
323
Capitol
296-4264
[email protected]
R
11
303
Capitol
297-8063
[email protected]
R
48
235
Capitol
296-3733
[email protected]
DFL
63
129
State
297-8061
[email protected]
R
19
322
Capitol
296-5981
[email protected]
R
47
124
Capitol
296-4154
[email protected]
DFL
20
103
State
296-5094
[email protected]
DFL
9
139
State
296-3205
Use Mail Form
DFL
44
121
State
297-8065
[email protected]
R
56
124
Capitol
296-4166
[email protected]
R
32
122
Capitol
296-2159
[email protected]
DFL
8
125
State
296-0293
[email protected]
R
22
205
Capitol
296-5650
[email protected]
DFL
54
119
State
296-5645
Use Mail Form
DFL
66
23
State
296-5537
Use Mail Form
DFL
39
15
State
296-4370
[email protected]
R
41
208
Capitol
296-6238
[email protected]
R
31
320
Capitol
296-5649
[email protected]
R
30
111
Capitol
296-4848
[email protected]
R
18
301
Capitol
296-4131
[email protected]
R
17
120
Capitol
296-5419
[email protected]
R
33
235
Capitol
296-1282
[email protected]
R
34
120
Capitol
296-4837
[email protected]
DFL
65
143
State
296-1802
Use Mail Form
R
26
309
Capitol
296-9457
[email protected]
R
15
G-24 Capitol
296-6455
[email protected]
DFL
7
149
State
296-4188
[email protected]
DFL
45
105
State
296-2889
Use Mail Form
R
35
226
Capitol
296-4123
[email protected]
R
24
317
Capitol
296-5713
[email protected]
DFL
3
135
State
296-4136
[email protected]
R
29
121
Capitol
296-3903
[email protected]
DFL
23
127
State
296-6153
[email protected]
DFL
57
117
State
297-8060
[email protected]
DFL
2
107
State
296-4196
[email protected]
DFL2719State
296-9248
[email protected]
DFL
1
145
State
296-8660
Use Mail Form
R
36
323
Capitol
296-5252
[email protected]
DFL
5
25
State
296-8017
[email protected]
DFL
62
131
State
296-4274
[email protected]
R
52
328
Capitol
296-4351
[email protected]
DFL
55
141
State
296-6820
[email protected]
R
51
306
Capitol
296-2556
[email protected]
n
29
minnesota house of representatives
Capitol ©Bill Nau
State Office Building
100 Rev. Dr. Martin
St. Paul, MN 55155-1206
www.house.leg.state.mn.us
• Find your district
• Find your representative
• Learn about your
representative
• Contact/email your
representative
If you don’t know what district
you are in, visit the Minnesota
House Web site to find out who
represents you.
30
Name
Abeler, Jim
Allen, Susan
Anderson, Bruce
Anderson, Sarah
Anderson, Paul
Anderson, Diane
Anzelc, Tom
Atkins, Joe
Banaian, King
Barrett, Bob
Beard, Michael
Benson, John
Benson, Mike
Bills, Kurt
Brynaert, Kathy
Buesgens, Mark
Carlson Sr., Lyndon
Champion, Bobby Joe
Clark, Karen
Cornish, Tony
Crawford, Roger
Daudt, Kurt
Davids, Greg
Davnie, Jim
Dean, Matt
Dettmer, Bob
Dill, David
Dittrich, Denise
Doepke, Connie
Downey, Keith
Drazkowski, Steve
Eken, Kent
Erickson, Sondra
Fabian, Dan
Falk, Andrew
Franson, Mary
Fritz, Patti
Garofalo, Pat
Gauthier, Kerry
Gottwalt, Steve
Greene, Marion
Greiling, Mindy
Gruenhagen, Glenn
Gunther, Bob
Hackbarth, Tom
Hamilton, Rod
Hancock, David
Hansen, Rick
Hausman, Alice
Hilstrom, Debra
Hilty, Bill
Holberg, Mary Liz
Hoppe, Joe
Hornstein, Frank
Hortman, Melissa
Hosch, Larry
Howes, Larry
Huntley, Thomas
Johnson, Sheldon
Kahn, Phyllis
Kath, Kory
Kelly, Tim
Kieffer, Andrea
Kiel, Debra
Kiffmeyer, Mary
Knuth, Kate
Koenen, Lyle
Kriesel, John
Laine, Carolyn
Lanning, Morrie
Leidiger, Ernie
n
PartyDistRmOffice PhoneEmail
R
48B
479 651-296-1729
[email protected]
DFL
61B
389
651-296-7152
[email protected]
R
19A
365 651-296-5063
[email protected]
R
43A
549 651-296-5511
[email protected]
R
13A
445 651-296-4317
[email protected]
R
38A
525 651-296-3533
[email protected]
DFL
03A
307 651-296-4936
[email protected]
DFL
39B
209 651-296-4192
[email protected]
R
15B
411 651-296-6612
[email protected]
R
17B
413 651-296-5377
[email protected]
R
35A
417 651-296-8872
[email protected]
DFL
43B
289 651-296-9934
[email protected]
R
30B
515 651-296-4378
[email protected]
R
37B
533 651-296-4306
[email protected]
DFL
23B
327 651-296-3248
[email protected]
R
35B
381 651-296-5185
[email protected]
DFL
45B
283 651-296-4255
[email protected]
DFL
58B
329 651-296-8659
[email protected]
DFL
61A
277 651-296-0294
[email protected]
R
24B
437 651-296-4240
[email protected]
R
08B
421 651-296-0518
[email protected]
R
17A
487 651-296-5364
[email protected]
R
31B
585 651-296-9278
[email protected]
DFL
62A
215 651-296-0173
[email protected]
R
52B
459 651-296-3018
[email protected]
R
52A
473 651-296-4124
[email protected]
DFL
06A
273 651-296-2190
[email protected]
DFL
47A
311 651-296-5513
[email protected]
R
33B
579 651-296-4315
[email protected]
R
41A
407 651-296-4363
[email protected]
R
28B
401 651-296-2273
[email protected]
DFL
02A
243 651-296-9918
[email protected]
R
16A
509 651-296-6746
[email protected]
R
01A
431 651-296-9635
[email protected]
DFL
20A
239 651-296-4228
[email protected]
R
11B
429 651-296-3201
[email protected]
DFL
26B
253 651-296-8237
[email protected]
R
36B
537 651-296-1069
[email protected]
DFL
07B
225 651-296-4246
[email protected]
R
15A
485 651-296-6316
[email protected]
DFL
60A
331 651-296-0171
[email protected]
DFL
54A
393 651-296-5387
[email protected]
R
25A
575 651-296-4229
[email protected]
R
24A
591 651-296-3240
[email protected]
R
48A
409 651-296-2439
[email protected]
R
22B
559 651-296-5373
[email protected]
R
02B
529 651-296-4265
[email protected]
DFL
39A
247 651-296-6828
[email protected]
DFL
66B
255 651-296-3824
[email protected]
DFL
46B
261 651-296-3709
[email protected]
DFL
08A
207 651-296-4308
[email protected]
R
36A
453 651-296-6926
[email protected]
R
34B
563 651-296-5066
[email protected]
DFL
60B
213 651-296-9281
[email protected]
DFL
47B
377 651-296-4280
[email protected]
DFL
14B
349 651-296-4373
[email protected]
R
04B
491 651-296-2451
[email protected]
DFL
07A
351 651-296-2228
[email protected]
DFL
67B
217 651-296-4201
[email protected]
DFL
59B
353 651-296-4257
[email protected]
DFL
26A
201 651-296-5368
[email protected]
R
28A
565 651-296-8635
[email protected]
R
56B
531 651-296-1147
[email protected]
R
01B
423 651-296-5091
[email protected]
R
16B
501 651-296-4237
[email protected]
DFL
50B
323 651-296-0141
[email protected]
DFL
20B
241 651-296-4346
[email protected]
R
57A
451 651-296-4342
[email protected]
DFL
50A
287 651-296-4331
[email protected]
R
09A
379 651-296-5515
[email protected]
R
34A
415 651-296-4282
[email protected]
minnesota house of representatives
Name
LeMieur, Mike
Lenczewski, Ann
Lesch, John
Liebling, Tina
Lillie, Leon
Loeffler, Diane
Lohmer, Kathy
Loon, Jenifer
Mack, Tara
Mahoney, Tim
Mariani, Carlos
Marquart, Paul
Mazorol, Pat
McDonald, Joe
McElfatrick, Carolyn
McFarlane, Carol
McNamara, Denny
Melin, Carly
Moran, Rena
Morrow, Terry
Mullery, Joe
Murdock, Mark
Murphy, Erin
Murphy, Mary
Murray, Rich
Myhra, Pam
Nelson, Michael V.
Nornes, Bud
Norton, Kim
O’Driscoll, Tim
Paymar, Michael
Pelowski Jr., Gene
Peppin, Joyce
Persell, John
Petersen, Branden
Peterson, Sandra
Poppe, Jeanne
Quam, Duane
Rukavina, Tom
Runbeck, Linda
Sanders, Tim
Scalze, Bev
Schomacker, Joe
Scott, Peggy
Shimanski, Ron
Simon, Steve
Slawik, Nora
Slocum, Linda
Smith, Steve
Stensrud, Kirk
Swedzinski, Chris
Thissen, Paul
Tillberry, Tom
Torkelson, Paul
Urdahl, Dean
Vogel, Bruce
Wagenius, Jean
Ward, John
Wardlow, Doug
Westrom, Torrey
Winkler, Ryan
Woodard, Kelby
Zellers, Kurt
PartyDistRmOffice PhoneEmail
R
12B
567 651-296-4247
[email protected]
DFL
40B
317 651-296-4218
[email protected]
DFL
66A
315 651-296-4224
[email protected]
DFL
30A
357 651-296-0573
[email protected]
DFL
55A
281 651-296-1188
[email protected]
DFL
59A
335 651-296-4219
[email protected]
R
56A
521 651-296-4244
[email protected]
R
42B
403 651-296-7449
[email protected]
R
37A
557 651-296-5506
[email protected]
DFL
67A
237 651-296-4277
[email protected]
DFL
65B
203 651-296-9714
[email protected]
DFL
09B
313 651-296-6829
[email protected]
R
41B
581 651-296-7803
[email protected]
R
19B
523 651-296-4336
[email protected]
R
03B
545 651-296-2365
[email protected]
R
53B
597 651-296-5363
[email protected]
R
57B
375 651-296-3135
[email protected]
DFL
05B
309
651-296-0172
[email protected]
DFL
65A
227 651-296-5158
[email protected]
DFL
23A
211 651-296-8634
[email protected]
DFL
58A
387 651-296-4262
[email protected]
R
10B
593 651-296-4293
[email protected]
DFL
64A
345 651-296-8799
[email protected]
DFL
06B
343 651-296-2676
[email protected]
R
27A
439 651-296-8216
[email protected]
R
40A
517 651-296-4212
[email protected]
DFL
46A
229 651-296-3751
[email protected]
R
10A
471 651-296-4946
[email protected]
DFL
29B
233 651-296-9249
[email protected]
R
14A
369 651-296-7808
[email protected]
DFL
64B
301 651-296-4199
[email protected]
DFL
31A
295 651-296-8637
[email protected]
R
32A
503 651-296-7806
[email protected]
DFL
04A
223 651-296-5516
[email protected]
R
49B
577 651-296-5369
[email protected]
DFL
45A
337 651-296-4176
[email protected]
DFL
27B
291 651-296-4193
[email protected]
R
29A
569 651-296-9236
[email protected]
DFL
05A
303 651-296-0170
[email protected]
R
53A
583 651-296-2907
[email protected]
R
51A
449 651-296-4226
[email protected]
DFL
54B
259 651-296-7153
[email protected]
R
22A
433 651-296-5505
[email protected]
R
49A
477 651-296-4231
[email protected]
R
18A
367 651-296-1534
[email protected]
DFL
44A
279 651-296-9889
[email protected]
DFL
55B
245 651-296-7807
[email protected]
DFL
63B
359 651-296-7158
[email protected]
R
33A
543 651-296-9188
[email protected]
R
42A
553 651-296-3964
[email protected]
R
21A
527 651-296-5374
[email protected]
DFL
63A
267 651-296-5375
[email protected]
DFL
51B
231 651-296-5510
[email protected]
R
21B
371 651-296-9303
[email protected]
R
18B
571 651-296-4344
[email protected]
R
13B
507 651-296-6206
[email protected]
DFL
62B
251 651-296-4200
[email protected]
DFL
12A
221 651-296-4333
[email protected]
R
38B
551 651-296-4128
[email protected]
R
11A
443 651-296-4929
[email protected]
DFL
44B
321 651-296-7026
[email protected]
R
25B
539 651-296-7065
[email protected]
R
32B
463 651-296-5502
[email protected]
my district:
my representative:
notes:
n
31
united states Minnesota house & senate
Please note that mail delivery to Washington can be
delayed by up to 10 days due to security screening. If
your message is urgent, fax your letter to Washington,
contact their district office, or send an email through
their Web site.
Congressman timothy Walz
First Congressional District of Minnesota
http://walz.house.gov
• Washington, DC
1529 Longworth House Office Building
Washington, DC 20515 • 202-225-2472
• Rochester
1134 7th Street NW
Rochester, MN 55901 • 507-206-0643
• Mankato
227 Main Street E, #220
Mankato, MN 56001 • 507-388-2149
Congressman John Kline
Second Congressional District of Minnesota
http://kline.house.gov
• Washington, DC
Washington, DC 20515
202-225-2271 • 202-225-2595 fax
• Burnsville
101 West Burnsville Pkwy., Ste. #201
Burnsville, MN 55337 • 952-808-1213
Congressman eric paulsen
Third Congressional District of Minnesota
http://paulsen.house.gov
• Washington, DC
126 Cannon House Office Building
202-225-2871 • 202-225-6351 fax
• eden prairie
250 Prairie Center Drive, Suite 230
Eden Prairie, MN 55344 • 952-405-8510
Congresswoman Betty McCollum
Fourth Congressional District of Minnesota
http://www.mccollum.house.gov
• Washington, DC
202-225-6631 • 202-225-1968 fax
• Saint Paul
165 Western Avenue N, Suite 17
St. Paul, MN 55102 • 651-224-9191
Congressman keith ellison
Fifth Congressional District of Minnesota
• Washington, DC
202-225-4755 • 202-225-4886 fax
• Minneapolis
2100 Plymouth Avenue N
Minneapolis, MN 55411 • 612-522-1212
32
n
Congresswoman Michele Bachmann
Sixth Congressional District of Minnesota
http://bachmann.house.gov
• Washington, DC
412 Cannon HOB
202-225-2331 • 202-225-6475 fax
• Woodbury
6043 Hudson Road, Suite 330
Woodbury, MN 55125 • 651-731-5400
• St. Cloud/Waite Park
110 2nd Street S, Suite 232
Waite Park, MN 56387 • 320-253-5931
senator Amy Klobuchar
http://klobuchar.senate.gov
Congressman Collin Peterson
Seventh Congressional District of Minnesota
http://collinpeterson.house.gov
• WASHINGTON, DC
2211 Rayburn HOB
202-225-2165 • 202-225-1593 fax
• Detroit Lakes
714 Lake Avenue, Suite 107
Detroit Lakes, MN 56501 • 218-847-5056
• Marshall
1420 East College Drive, SW/WC
Marshall, MN 56258 • 507-537-2299
• Montevideo
100 First Street N
Montevideo, MN 56265 • 320-269-8888
• Red Lake Falls
MN Wheat Growers Building
2603 Wheat Drive
Red Lake Falls, MN 56750 • 218-253-4356
• Redwood Falls
230 East 3rd Street, P.O. Box 50
Redwood Falls, MN 56283 • 507-637-2270
• Willmar
320 4th St SW, Centre Point Mall
Willmar, MN 56201 • 320-235-1061
• Moorhead
121 4th Street S
Moorhead, MN 56560 • 218-287-2219
Congressman Chip cravaack
Eighth Congressional District of Minnesota
http://chipcravaack.house.gov
• WASHINGTON, DC
508 Cannon HOB
202-225-6211 • 202-225-0699 fax
• NORTH BRANCH
6448 Main St., Suite Ste 6
North Branch, Minnesota 55056 • 651-237-8220
or 1-888-563-7390
Fax: 651-237-8225
• Washington, DC
302 Hart Office Building
202-224-3244 • 202-228-2186 fax
• Metro
1200 Washington Avenue S, Suite 250
Minneapolis, MN 55415 • 612-727-5220
• Rochester
1134 7th Street NW
Rochester, MN 55901 • 507-288-5321
• Iron Range
Olcott Plaza, Suite 105
820 9th Street N
Virginia, MN 55792 • 218-741-9690
senator al franken
http://franken.senate.gov
• Washington, DC
320 Hart Senate Office Building
Washington, DC 20510 • 202-224-5641
• st paul
60 East Plato Blvd, Suite 220
Saint Paul, MN 55107 • 651-221-1016
• saint peter
208 S Minnesota Ave., Suite 6
Saint Peter, MN 56082 • 507-931-7345
• saint cloud
916 W St. Germain St., Suite 110
Saint Cloud, MN 56301 • 320-251-2721
• duluth
515 W 1st St., Suite 104
Duluth, MN 55082 • 218-722-2390
minnesota pharmacy resources
university of minnesota
College of Pharmacy
College of Pharmacy
University of Minnesota
5-130 Weaver-Densford Hall
308 Harvard Street SE
Minneapolis, MN 55455
612-624-1900
612-624-2974 fax
www.pharmacy.umn.edu
Dean Marilyn K. Speedie, Ph.D.
612-624-1900
university of minnesota
College of Pharmacy, duluth
University of Minnesota
College of Pharmacy, Duluth
386 Kirby Plaza
1208 Kirby Drive
Duluth, MN 55812-3095
218-726-6000
218-726-6500 fax
www.pharmacy.umn.edu/duluth
minnesota board of pharmacy
The Minnesota Board of Pharmacy (BOP) exists to protect the
public from adulterated, misbranded, and illicit drugs, and from
unethical or unprofessional conduct on the part of pharmacists or
other licensees, and to provide a reasonable assurance of professional competency in the practice of pharmacy by enforcing the
Pharmacy Practice Act M.S. 151, State Controlled Substances Act
M.S. 152 and various other statutes. The board strives to fulfill
its mission through a combination of regulatory activity, technical
consultation and support for pharmacy practices through
the issuance of advisories on pharmacy practice issues, and through
education of pharmacy practitioners.
The Board of Pharmacy consists of seven board members,
appointed by the governor; five board members must be pharmacists, and two members must be public members. The board regulates pharmacists, pharmacies, pharmacy technicians, controlled
substance researchers, drug wholesalers and drug manufacturers.
The board approves licenses or registrations for these individuals
or businesses, and also decides when to impose disciplinary action.
Minnesota Board of Pharmacy
Cody C. Wiberg, Executive Director
2829 University Ave, SE, Suite 530
Minneapolis, MN 55414
651-201-2825
651-201-2837 fax
800-627-3529 hearing impaired
www.phcybrd.state.mn.us
Minnesota Board of Pharmacy Members
President: James Koppen
Vice President: Laura J. Schwartzwald
Pharmacist Members: Karen Bergrud, Bob Goetz, Kay Hanson
Public Members: Ikram–ul–Huq, Stuart Williams
minnesota department
of human services
The Minnesota Department of Human Services (DHS) helps
people meet their basic needs by providing or administering health
care coverage, economic assistance, and a variety of services for
children, people with disabilities and older Minnesotans.
DHS programs include Medical Assistance (MA), MinnesotaCare,
Minnesota Family Investment Program (Minnesota’s version of
the federal Temporary Assistance for Needy Families program),
General Assistance (GA), the Prescription Drug Program, child
protection, child support enforcement, child welfare services, and
services for people who are mentally ill, chemically dependent or
have physical or developmental disabilities.
www.dhs.state.mn.us
Drug Utilization Review board (DUR)
The Drug Utilization Review Board (DUR) selects specific drug
entities or therapeutic classes to be targeted for provider and recipient educational interventions, and provides guidelines for their
use. The DUR board is comprised of four licensed physicians, at
least three licensed pharmacists and one consumer representative,
with the remaining members being licensed health care professionals with clinically appropriate knowledge in prescribing, dispensing, and monitoring outpatient drugs. DUR board meetings are
held four times a year. Appointing authority: Commissioner of
Human Services. Compensation: $50 per member per meeting
plus mileage. (Minnesota Statutes 256B.0625, subd. 13a)
Drug Formulary Committee (DFC)
The Drug Formulary Committee (DFC) is charged with reviewing and recommending which drugs require authorization. The
DFC also reviews drugs for which coverage is optional under
federal and state law. (For possible inclusion in the Medicaid
fee-for-service formulary.) The DFC is comprised of four physicians, at least three pharmacists, a consumer representative, and
knowledgeable health care professionals. DFC meetings are open
to the public and public comments are taken for an additional 30
days following a DFC recommendation to require prior authorization for a drug. The Department of Human Services provides
the DFC with information regarding the impact that placing a
drug on authorization will have on the quality and cost of patient
care. Appointing authority: Commissioner of Human Services.
Compensation: None. (Minnesota Statutes 256B.0625, subd. 13)
n
33
2012 MPha award categories
recognize those making a difference
in the profession of pharmacy.
The association annually recognizes leaders in the field of
pharmacy. Please help us identify pharmacy leaders by submitting a nomination form(s) and letters of support to the MPhA
office. More information can be found on the MPhA Web site.
Following are descriptions of each award, and past recipients,
beginning with the most recent 2011 recipients.
Harold r. popp award
Sponsored by the Minnesota Pharmacists Association, the Popp
Award was established by MPhA in 1969 in honor of the late
Senator Harold R. Popp to recognize one pharmacist annually
for outstanding services to the profession of pharmacy. This is
the highest honor bestowed by the association. This award is
presented at the MPhA Annual Meeting.
Rod Carter
Marilyn Eelkema
Randy Seifert
Chris Koentopp
Paul Iverson
Dale Olson
Steven Simenson
Marilyn K. Speedie
James Armbrustser
John Stevens
Herbert Whittemore
Michael A. Kelly
Marv Dyrstad
Keith Pearson
Julie K. Johnson
David Holmstrom
Gary Raines
Barb Jones
Karl Leupold
Gilbert Banker
Howard Juni
Doris Calhoun
Donald P. Gibson
S. Bruce Benson
Gary Schneider
Russ Boogren
Carl Oberg Jr.
Barry Krelitz
Roland Leuzinger
Lawrence C. Weaver
Lowell J. Anderson
John H. Nelson
Frank D. DiGangi
Neal W. Schwartau
Kendall B. Macho
J. Roger Vadheim
Kitty Alcott
William Appel
Russel F. King
Charles V. Netz
Henry M. Moen
Arnold D. Delger
John E. Quistgard
bowl of hygeia
Sponsored by Wyeth Pharmaceuticals, the Bowl of Hygeia recognizes pharmacists who possess outstanding records of civic
leadership in their own communities, from which their specific
identification as a pharmacist reflects well on the profession.
This award is presented at the MPhA Annual Meeting.
John Hoeschen
Gregory Trumm
Patricia Lind
Gary Raines
Vern Peterson
Paul Iverson
Brian Isetts
Steven T. Simenson
Richard C. Sundberg
Terry L. Hartmann
Sherwood Peterson, Jr.
Julie K. Johnson
Dale Olson
John Stevens
Mike Hart
Howard Juni
Robert Reutzel
Robert Setzer
34
Chuck Frost
Robert Warren
Don Dinndorf
Herb Whittemore
James Alexander
John H. Nelson
Donald P. Gibson
Brad Stanius
Gary Schneider
Richard Kienzle
Harold McMahon
Doris Calhoun
Andrew Johnson
Robert W. Foster
Lowell J. Anderson
Ronald O. Leuzinger
Earl A. Schwerman
Arnold D. Delger
n
Carl W. Oberg, Jr.
Russell Boogren, Jr.
Jack R. Andrews
Frank E. DiGangi
Roger Vadheim
Russell F. King, Jr.
Burton Magnuson
Andrew G. Sanders
Bernard H. Trygstad
Willard J. Hadley
Maynard L. Johnson
Argyll W. Peterson
William D. Nelson
Orace Hanson
Paul C. Anderson
Arnold M. Grais
Ted F. Maier
distinguished young pharmacist
Sponsored by Pharmacists Mutual Companies, the
Distinguished Young Pharmacist Award recognizes a young
pharmacist within his/her first ten years of practice who has distinguished himself/herself in the field of pharmacy. This pharmacist is also a participant in national pharmacy associations,
professional programs, state association activities and/or community service. This award is presented at the MPhA Annual
Meeting.
Sarah Leslie
Dan Rehrauer
Julie Fike
Sarah Westberg
Stephanie Davis
Michelle Aytay
Mark Dewey
Terry Hietpas
Todd D. Sorensen
Michelle Johnson
Debra Sisson
Laura Odell
Molly Ekstrand
Denise Wolff
Roger McDannold
John Hoeschen
Jason Varin
Karen Schramm
Scott Benson
Sherwood Peterson, Jr.
Nancy Ruhland
Mary Hayney
Jeffrey Shapiro
Lucy Johnson
Kathryn Nygren
Excellence in Innovation
Sponsored by Upsher Smith, the Excellence in Innovation
award recognizes innovative pharmacy practice resulting in
improved patient care. This award is presented at the MPhA
Annual Meeting.
Camille Kundel
Amanda Brummel
Shannon Reidt
Bruce Thompson
Vyvy Vo
April Hanson
Jeremy Johnson
Daniel J. Rehrauer
J.D. Anderson
Tiffany D. Elton
Ronald Hartmann
Paul Iverson
Sherwood Peterson Jr.
Peters Institute
Laura Miller
Tom Jackson
John Loch
Keith Pearson
PHARMACY TECHNICIAN AWARD
Presented by MPhA, the Pharmacy Technician Award recognizes a pharmacy technician in any practice setting who
demonstrates leadership in their work and in their community.
This includes demonstrating professionalism by participation in
pharmacy association, professional programs and/or community
service, promoting teamwork within the pharmacy, providing
leadership and serving as a role model for coworkers, developing
or assisting development of efficient safe procedures that support
the provision of pharmaceutical care. This award is presented at
the annual MPhA/MSHP Technician Conference.
Robbin Leach
Carole Lentz
Tina Nathe
Jennifer Sandberg
Sandra Christensen
Cheryl Blegen
Jamie Jesnowski
Heidi Miller
Please provide a letter of support for each award nominee describing in
detail the reasons for the MPhA Awards Committee to consider your nominee. Include specific examples and/or details. Attach your nomination letter
and any supporting documents to the form on page 26, including a current CV of nominee if possible. Nominations that do not include adequate
information will not be considered until missing information is submitted.
Nominators will be notified when nominations are received by the MPhA
office and if additional information is required. Please see the MPhA Web
site for additional award information and forms: www.mpha.org.
The Minnesota Pharmacists Foundation is an organization that invests
in public health through the profession of pharmacy.
The Minnesota Pharmacists Foundation formed in May 2003 to enhance patient care practices and the development of leadership
opportunities for Minnesota pharmacists. The foundation promotes and communicates leading-edge practice innovations that consistently
demonstrate improved patient outcomes.
Foundation GOALS:
Create a strong future for pharmacy by investing in its pharmacists of tomorrow.
Award annual scholarships to pharmacy students attending the University of
Minnesota campuses in Duluth and Minneapolis.
Support leadership training to potential Minnesota pharmacist leaders.
Foundation Activities:
Created the AWARxE campaign to educate communities and individuals on the
dangers of prescription medications.
Hosts the annual Herbie Cup to raise money for the Herb and Addie
Whittemore scholarship.
Developed the Student Education Fund to invest in our future pharmacy leaders.
Awards scholarships annually to pharmacy students at the University of
Minnesota campuses in Duluth and Minneapolis.
Helped bring the Meth Watch program to Minnesota to help educate consumers
and retailers on meth awareness.
“We get closer to achieving our goals every day with
your support...any level of support is appreciated.”
n
35
advertising:
minnesota pharmacist
quarterly journal
The Minnesota Pharmacist is a quarterly journal publication of
the Minnesota Pharmacists Association (MPhA) with a circulation of 1,800. The leading information resource for pharmacy
in Minnesota, each journal includes in-depth articles on clinical,
practice, industry, management and legislative issues.
approval & placement: All advertising is subject to publisher’s approval. Acceptance of advertisement does not constitute
endorsement, and is subject to space availability. To reserve space
in an upcoming journal, submit an Advertising Purchase Request
form by the indicated due date. Orders must be received before
deadline to hold space. Please call ahead if you have deadline
conflicts.
Errors: The publisher shall not be liable for slight changes or
typographical errors which do not lessen the value of the advertisement. The publisher shall not be liable for any other errors
appearing in any advertisement unless the magazine received
corrected copy before the issue deadline with corrections plainly
noted.
indemnification: All advertisements are accepted and
published on the representation that the advertiser and/or the
advertising agency are authorized to publish the entire contents
and subject matter thereon, as confirmed by verbal or written
order from the person representing the advertiser and/or advertising agency. The advertiser agrees to indemnify and hold the publisher and production company harmless from any and all liability,
claims, demands or damages arising out of the advertising or on
behalf of the advertiser. Such indemnity includes the provision
of a defense to any actions or claims and the payment of cost and
attorney’s fees in connection therewith.
supplying files: Files may be emailed or mailed to the
MPhA office.
Preferred mailed formats: CD saved for MAC use.
Preferred email formats: High/Press quality PDF with proper color
separations.
Accepted file formats: High/Press quality PDF, EPS, TIF, or JPEG
(maximum quality).
When supplying files other than PDF, you must include all original
graphics used in file and all fonts used. Please ensure that your files
color separate correctly.
spring - April
• Advertising due March 15, 2012
summer - july
• Advertising due June 15, 2012
fall - october
• Advertising due September 14, 2012
Contact Anna Wrisky at the MPhA office for more information: [email protected] or 651-290-6298.
• $100 frequency discount available on annual reservation (4
issues).
• MPhA meeting exhibitors receive $100 advertising credit
when placing an ad in the issue preceding the event.
Signed exhibiting confirmation notice must be received by our
office for discount to be effective.
Ad size and Rates
SizeDimensionsBlack & White
CMYK
Full page
8.5 x 11
$740
$1,470
Half page
3.75 x 9.5 vertical
7.5 x 4.75 horizontal
$485
$485
$1,215
$1,215
Third page
2.9 x 9.5 vertical
$430
$430
$1,160
$1,160
Fourth page
3.75 x 4.75 vertical
$335
$335
$1,065
$1,065
Eighth page
2 x 3.5 vertical
3.5 x 2 horizontal
$200
$200
N/A
N/A
Classified
over 75 words
under 75 words
$50
$25
N/A
N/A
2012 Editorial Calendar and submission dates
The Leading Information Resource for Pharmacy in Minnesota
Month/IssueFocus
Editorial Advertisement
DeadlineDeadlineMails
spring
Pharmacy Legislative Day Wrap
Mid-Session Report
March 1
March 15
April
summer
PharmPAC Newsletter
Annual Meeting Wrap
Session Wrap
House of Delegates Report
New MPhA Board Members
May 31
June 15
July
fall
Fall Clinical Symposium Wrap
Promote Pharmacy Legislative Day
Award Nomination Forms
August 31
September 15
October
WINTER
Pharmacist Resource Guide
December 1
December 15
January
Year in Review
AWARxE Update
Every issue
President’s Desk
Executive’s Report
Public Affairs
Feature articles
MPhA featured member benefit
Pharmacy & the Law/Financial Forum
Exhibitors are eligible for a discounted advertising rate for the issue promoting the event.
The Minnesota Pharmacist is a quarterly journal publication of the Minnesota Pharmacists Association (MPhA). All advertising and
feature articles are subject to publisher’s approval. Acceptance of advertisement or editorial content does not constitute endorsement, and
is subject to space availability.
MPhA welcomes editorial content that has a direct link to professional managment, growth or inititives in the pharmacy field. To be considered for publication, submit your name (along with any connections to a specific product or company) with a sample or explanation
of your editorial content to Anna Wrisky at [email protected] or fax to 651-290-2266. Authors will be notified if their submissions are
accepted for publication. All authors receive a complimentary copy of the issue containing their content.
n
37
spring - April
• Advertising due March 15, 2012
summer - july
• Advertising due June 15, 2012
fall - october
• Advertising due September 14,
2012
advertising request form
quarterly journal
Company Advertising: ______________________________________________________
issue:
size:
Mail or Fax to Anna Wrisky
1000 Westgate Drive • Suite 252
St. Paul, MN 55114
651-697-1771 • 651-290-2266 fax
• Tear sheets will be supplied with
invoice or receipts to the billing
address provided.
• $100 frequency discount per issue
on annual reservation (4 issues).
• MPhA meeting exhibitors
receive $100 advertising credit on
orders when placed in the issue
preceding the event. Signed
exhibiting confirmation notice must be
received by our office for discount
to be effective.
• Include yourself on our journal mailing list by becoming an
Associate Member! Annual
subscriptions of $100 are
also available.
Winter
Full
color:
Half
Spring
Third
Summer
Fall
Fourth
Annual (4 issues)
Eighth
Black (Eighth and Classified are black only)
Classified: -75 / +75
Full Color
Spot Color
total advertising cost: $_______________________
billing:
Above Company
Advertising Agency
Firm: ___________________________________________________________________
Address: _________________________________________________________________
City: ___________________________________ State: ______ ZIP: _______________
Contact Person: ___________________________________________________________
Phone: ______________________________ Fax: _______________________________
E-mail: __________________________________________________________________
payment:
Invoice me
Check enclosed
Charge: MC / Visa / Amex / Discover
number:___________________________________________________________ expiration:______________
name on card:________________________________________________
3 or 4 digit code:______________
billing address:____________________________________________________________________________
city:______________________________________________ state:__________ zip:_____________________
signature:_________________________________________________________
_______________________
Invoice/ job number to reference (if applicable): ______________________
• Questions? Contact Anna Wrisky
at the MPhA office: annaw@ewald.
com or 651-290-6298.
This form will be used to secure space in MPhA’s 2012 journals and will act as an intent to
purchase advertising.
Name and Title (please print): ________________________________________________
Signature: _________________________________________________ Date: _________
38
n
Two Great Ways to Earn Rewards
With McKesson and Pace Alliance
Our dedication to your continued success as an independent pharmacy means
making an impact on our industry, as well as your bottom line. That is why we’ve
strengthened our relationship to deliver even greater value to McKesson Distribution
customers who are members of Pace Alliance.
Eligible customers now have the opportunity to earn up to 13% in an additional monthly
rebate on net McKesson OneStop Generics® purchases, while implementing valuable businessbuilding solutions. Plus, as more Pace Alliance members become McKesson customers, the rebate
percentages can get even higher.
Fewer Requirements,
Bigger Rewards
Perform at Your Peak
with Health Mart®
The Pace Performance Rewards program now
provides even greater rewards based on your
purchasing commitment. Not only have we
enhanced the rebates, but we’ve eased the
requirements. So all Pace members who use
McKesson as their primary wholesaler and
participate in the following valuable McKesson
programs have an opportunity to earn greater
rewards:
In addition to monthly rebates of up to 13%
(or more) on qualified OneStop purchases,
Health Mart pharmacies can earn up to
$10,000 per year in technology rebates
through the Pace Peak Performance
Rewards program.1 Pace Peak Performance
Rewards is available exclusively to Health Mart
franchisees who participate in:
– McKesson’s Generics Purchasing
Rewards Program
– ASAP and ASAP Plus
autoship programs
SM
SM
generics
– GenericsConnect , a regularly scheduled
call from a dedicated generics specialist
SM
– Controlled Substance Ordering System (CSOS)
– McKesson’s Generics Purchasing
Rewards Program
– ASAPSM and ASAP PlusSM generics
autoship programs
– GenericsConnectSM, a regularly scheduled
call from a dedicated generics specialist
– Controlled Substance Ordering System (CSOS)
– AccessHealth®
– McKesson Reimbursement Advantage
“By strengthening our partnership with McKesson, Pace Alliance can
continue to focus on our advocacy efforts and deliver even greater value
to our members.”
Curtis J. Woods, R.Ph.
President and CEO
Pace Alliance
1 An enrollment agreement that includes applicable terms and conditions is available on request.
©2012 McKesson Corporation. All rights reserved. RTL-05874-02-12
Pace and McKesson:
A Complete Solution for
Independent Pharmacy
Since 1985, Pace Alliance has been
working on behalf of independent
community pharmacies to help
them decrease costs, while
generating revenue for state
pharmacy organizations.
Today, Pace is owned by 19
state pharmacy organizations
and is dedicated to protecting
and advancing the profession
for community pharmacies
nationwide.
Together, Pace and McKesson are
dedicated to helping community
pharmacies thrive in today’s
marketplace. As part of this
continued commitment to your
success, Pace members can benefit
from McKesson’s revenue-building
solutions and cost-reducing
programs and services.
Every Customer counts!
Dakota Drug Inc.
1101 Lund Boulevard
Anoka, MN 55303
phone (763) 432-4333
fax (763) 421-0661
www.dakdrug.com
The
As the Midwest’s only Independent Drug
Wholesaler, Dakota Drug has grown and developed by
addressing the needs of you, the Community Pharmacist, and by
providing assistance to ensure your success.
We are committed to personal service and welcome
the opportunity to assist you.
Upper Midwest’s Independent Healthcare Distributor

PhARMACY - Minnesota Pharmacists Association

Transcription

Similar documents

Harding Students Lobbied for Arkansas Therapeutic Substitution Law

PDF - First Nations Health Authority

FMP Direct Service

It`s Digest Time Again

Qmatic Pharmacy - Customer Flow Management

PharmacistsBargainin..

New cancer drug inquiry

3 - BP Healthcare